JPH0372229B2 - - Google Patents
Info
- Publication number
- JPH0372229B2 JPH0372229B2 JP2530784A JP2530784A JPH0372229B2 JP H0372229 B2 JPH0372229 B2 JP H0372229B2 JP 2530784 A JP2530784 A JP 2530784A JP 2530784 A JP2530784 A JP 2530784A JP H0372229 B2 JPH0372229 B2 JP H0372229B2
- Authority
- JP
- Japan
- Prior art keywords
- benzoxepino
- lower alkyl
- oxazine
- hexahydro
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 38
- 125000000217 alkyl group Chemical group 0.000 claims description 37
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 36
- -1 2-furanylmethyl Chemical group 0.000 claims description 25
- 150000003839 salts Chemical class 0.000 claims description 18
- 239000001257 hydrogen Substances 0.000 claims description 15
- 229910052739 hydrogen Inorganic materials 0.000 claims description 15
- 150000002431 hydrogen Chemical class 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- IHKALFITVBQHPG-UHFFFAOYSA-N 2h-[1]benzoxepino[5,4-b][1,4]oxazine Chemical compound C1=COC2=CC=CC=C2C2=C1N=CCO2 IHKALFITVBQHPG-UHFFFAOYSA-N 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- KLBCQBRUFJODSQ-UHFFFAOYSA-N 1-benzoxepin-5-ol Chemical compound OC1=CC=COC2=CC=CC=C12 KLBCQBRUFJODSQ-UHFFFAOYSA-N 0.000 claims description 4
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 claims description 4
- 230000010933 acylation Effects 0.000 claims description 4
- 238000005917 acylation reaction Methods 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 4
- 125000001153 fluoro group Chemical group F* 0.000 claims description 4
- DNUJVGBNIXGTHC-UHFFFAOYSA-N 3,6-dihydro-2h-oxazine Chemical compound C1NOCC=C1 DNUJVGBNIXGTHC-UHFFFAOYSA-N 0.000 claims description 2
- 150000008065 acid anhydrides Chemical class 0.000 claims description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims 1
- XISPDFMAOWZEQG-UHFFFAOYSA-N 4h-1,4-oxazin-3-one Chemical compound O=C1COC=CN1 XISPDFMAOWZEQG-UHFFFAOYSA-N 0.000 claims 1
- 150000004893 oxazines Chemical class 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- 239000000243 solution Substances 0.000 description 35
- 239000000203 mixture Substances 0.000 description 28
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- 238000000034 method Methods 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 230000008018 melting Effects 0.000 description 12
- 238000002844 melting Methods 0.000 description 12
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 11
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 239000012280 lithium aluminium hydride Substances 0.000 description 8
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 8
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 238000001953 recrystallisation Methods 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 150000004678 hydrides Chemical class 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic acid anhydride Natural products CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 239000011976 maleic acid Substances 0.000 description 4
- 229960005181 morphine Drugs 0.000 description 4
- 239000003158 myorelaxant agent Substances 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- OJZWTYXMABCBFG-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1-benzoxepin-5-ol Chemical compound OC1CCCOC2=CC=CC=C12 OJZWTYXMABCBFG-UHFFFAOYSA-N 0.000 description 3
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 235000011054 acetic acid Nutrition 0.000 description 3
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 3
- 239000012346 acetyl chloride Substances 0.000 description 3
- 239000000538 analytical sample Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 3
- 239000008116 calcium stearate Substances 0.000 description 3
- 235000013539 calcium stearate Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 150000002688 maleic acid derivatives Chemical class 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- YRMMRFYPKHSIDT-PSASIEDQSA-N (4r,5r)-4-amino-2,3,4,5-tetrahydro-1-benzoxepin-5-ol Chemical compound O[C@H]1[C@H](N)CCOC2=CC=CC=C21 YRMMRFYPKHSIDT-PSASIEDQSA-N 0.000 description 2
- TVSPPYGAFOVROT-UHFFFAOYSA-N 2-phenoxybutanoic acid Chemical compound CCC(C(O)=O)OC1=CC=CC=C1 TVSPPYGAFOVROT-UHFFFAOYSA-N 0.000 description 2
- YHWMFDLNZGIJSD-UHFFFAOYSA-N 2h-1,4-oxazine Chemical compound C1OC=CN=C1 YHWMFDLNZGIJSD-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FNPPLPIIUUIIKV-BTJKTKAUSA-N C(\C=C/C(=O)O)(=O)O.O1C2=C(N=CC1)C=COC1=C2C=CC=C1 Chemical compound C(\C=C/C(=O)O)(=O)O.O1C2=C(N=CC1)C=COC1=C2C=CC=C1 FNPPLPIIUUIIKV-BTJKTKAUSA-N 0.000 description 2
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 2
- 229940038472 dicalcium phosphate Drugs 0.000 description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007972 injectable composition Substances 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 229940035363 muscle relaxants Drugs 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000007916 tablet composition Substances 0.000 description 2
- 125000005270 trialkylamine group Chemical group 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UWYVPFMHMJIBHE-OWOJBTEDSA-N (e)-2-hydroxybut-2-enedioic acid Chemical compound OC(=O)\C=C(\O)C(O)=O UWYVPFMHMJIBHE-OWOJBTEDSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- PKRSYEPBQPFNRB-UHFFFAOYSA-N 2-phenoxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1OC1=CC=CC=C1 PKRSYEPBQPFNRB-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- DENSSQCEICDSJN-UHFFFAOYSA-N 2h-1,4-oxazine;hydrochloride Chemical compound Cl.C1OC=CN=C1 DENSSQCEICDSJN-UHFFFAOYSA-N 0.000 description 1
- RMQWHXDLQIILBC-UHFFFAOYSA-N 2h-oxazine;hydrochloride Chemical compound Cl.N1OC=CC=C1 RMQWHXDLQIILBC-UHFFFAOYSA-N 0.000 description 1
- KNTMEDNZPJADJU-UHFFFAOYSA-N 3,4-dihydro-2h-1-benzoxepin-5-one Chemical compound O=C1CCCOC2=CC=CC=C12 KNTMEDNZPJADJU-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 238000000023 Kugelrohr distillation Methods 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000428199 Mustelinae Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000906446 Theraps Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229930188620 butyrolactone Natural products 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- VXIVSQZSERGHQP-UHFFFAOYSA-N chloroacetamide Chemical compound NC(=O)CCl VXIVSQZSERGHQP-UHFFFAOYSA-N 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000002664 inhalation therapy Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- QHDRKFYEGYYIIK-UHFFFAOYSA-N isovaleronitrile Chemical compound CC(C)CC#N QHDRKFYEGYYIIK-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 229960004715 morphine sulfate Drugs 0.000 description 1
- GRVOTVYEFDAHCL-RTSZDRIGSA-N morphine sulfate pentahydrate Chemical compound O.O.O.O.O.OS(O)(=O)=O.O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O.O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O GRVOTVYEFDAHCL-RTSZDRIGSA-N 0.000 description 1
- DAZXVJBJRMWXJP-UHFFFAOYSA-N n,n-dimethylethylamine Chemical compound CCN(C)C DAZXVJBJRMWXJP-UHFFFAOYSA-N 0.000 description 1
- UVBMZKBIZUWTLV-UHFFFAOYSA-N n-methyl-n-propylpropan-1-amine Chemical group CCCN(C)CCC UVBMZKBIZUWTLV-UHFFFAOYSA-N 0.000 description 1
- 150000002829 nitrogen Chemical group 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 1
- 229910000343 potassium bisulfate Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- NESLWCLHZZISNB-UHFFFAOYSA-M sodium phenolate Chemical compound [Na+].[O-]C1=CC=CC=C1 NESLWCLHZZISNB-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 150000003628 tricarboxylic acids Chemical class 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
æ¬çºæã¯ããšãã«ç°åã¯ã¢ããçªçŽ ååã§çœ®æ
ãããã2HâãïŒããã³ãºãªãã»ãããïŒïŒïŒâ
ïœãâïŒïŒïŒâãªããµãžã³èªå°äœã«é¢ããããã
詳ããã¯æ¬çºæã¯æ¬¡ã®äžè¬åŒ ïŒåŒäžïŒ²ãšR2ã¯åã æ°ŽçŽ ããã«ãªããã¯ãã
åã³äœçŽã¢ã«ãã«ãããªã矀ããéžã°ããR2ã¯
æ°ŽçŽ ãäœçŽã¢ã«ãã«ãããšãã«äœçŽã¢ã«ãã«ãäœ
çŽã¢ã«ã³ãã·äœçŽã¢ã«ãã«ãã·ã¯ããããã«ã¡ã
ã«ãïŒâãã©ãã«ã¡ãã«ãåã³R3ãšR4ãåã æ°Ž
çŽ åã¯äœçŽã¢ã«ãã«ã§ããäœçŽã¢ã«ãã«
ãããã2HâãïŒããã³ãºãªãã»ãããïŒïŒïŒâ
ïœãâïŒïŒïŒâãªããµãžã³èªå°äœã«é¢ããããã
詳ããã¯æ¬çºæã¯æ¬¡ã®äžè¬åŒ ïŒåŒäžïŒ²ãšR2ã¯åã æ°ŽçŽ ããã«ãªããã¯ãã
åã³äœçŽã¢ã«ãã«ãããªã矀ããéžã°ããR2ã¯
æ°ŽçŽ ãäœçŽã¢ã«ãã«ãããšãã«äœçŽã¢ã«ãã«ãäœ
çŽã¢ã«ã³ãã·äœçŽã¢ã«ãã«ãã·ã¯ããããã«ã¡ã
ã«ãïŒâãã©ãã«ã¡ãã«ãåã³R3ãšR4ãåã æ°Ž
çŽ åã¯äœçŽã¢ã«ãã«ã§ããäœçŽã¢ã«ãã«
ãåŒããããªã矀ããéžã°ãããã®ã§ããïŒ
ãæãããã·ã¹åã³ãã©ã³ã¹ïŒ4aïŒ11bïŒâïŒïŒ
ïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâ2HãïŒã
ãã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªã
ãµãžã³èªå°äœãåã³ãã®è£œè¬äžåãå ¥ããããå¡©
ã«é¢ãããã®ã§ããããããã®èªå°äœã¯æçšãªé®
ç掻æ§åã³çå åŒç·©æŽ»æ§ãæããŠãããæ¬çºæã¯
ãããã®èªå°äœãè¯å¥œãªåçã§éœåãã補é åºæ¥
ãæ¹æ³ãæŽã«é瀺ããŠããã äžã®äžè¬åŒïŒïŒãããããããã«ããã³ãºãª
ãã»ããéšåã®ãã³ãŒãã€ãéšåã¯èšå·ïŒ²ãšR1
ã«ãã€ãŠç€ºãããããã«çœ®æãããŠãããåã¯é
眮æã§ããã眮æãããŠãããšãã¯ãçš®ã ã®çœ®æ
åºã¯ãã³ãŒãã€ãéšåã®åã€ã®äœçœ®å³ã¡ïŒïŒïŒïŒ
10åã¯11ã®ä»»æã®äžã€ã«äœçœ®åºæ¥ããæ¬çºæã®ç¯
å²å ã«ãããã®ãšããŠå å«ãããçš®ã ã®çœ®æåºã«
ã¯ãã«ãªããã¯ãããåã³äœçŽã¢ã«ãã«åºã®åç¬
åã¯çµã¿åããå«ãŸããã æŽã«ç°ã®çªçŽ ååã¯èšå·R2ã§ç€ºãããããã«
眮æãããŠããŠãé眮æã®ãŸãŸã§ãã€ãŠãããã
æ¬çºæã®ç¯å²å ã«å«ãŸããèšå·R2ã®çš®ã ã®çœ®æ
åºã¯äœçŽã¢ã«ãã«ãããšãã«äœçŽã¢ã«ãã«ãäœçŽ
ã¢ã«ã³ãã·äœçŽã¢ã«ãã«ãã·ã¯ããããã«ã¡ã
ã«ãïŒâãã©ãã«ã¡ãã«ãäœçŽã¢ã«ãã«
ïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâ2HãïŒã
ãã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªã
ãµãžã³èªå°äœãåã³ãã®è£œè¬äžåãå ¥ããããå¡©
ã«é¢ãããã®ã§ããããããã®èªå°äœã¯æçšãªé®
ç掻æ§åã³çå åŒç·©æŽ»æ§ãæããŠãããæ¬çºæã¯
ãããã®èªå°äœãè¯å¥œãªåçã§éœåãã補é åºæ¥
ãæ¹æ³ãæŽã«é瀺ããŠããã äžã®äžè¬åŒïŒïŒãããããããã«ããã³ãºãª
ãã»ããéšåã®ãã³ãŒãã€ãéšåã¯èšå·ïŒ²ãšR1
ã«ãã€ãŠç€ºãããããã«çœ®æãããŠãããåã¯é
眮æã§ããã眮æãããŠãããšãã¯ãçš®ã ã®çœ®æ
åºã¯ãã³ãŒãã€ãéšåã®åã€ã®äœçœ®å³ã¡ïŒïŒïŒïŒ
10åã¯11ã®ä»»æã®äžã€ã«äœçœ®åºæ¥ããæ¬çºæã®ç¯
å²å ã«ãããã®ãšããŠå å«ãããçš®ã ã®çœ®æåºã«
ã¯ãã«ãªããã¯ãããåã³äœçŽã¢ã«ãã«åºã®åç¬
åã¯çµã¿åããå«ãŸããã æŽã«ç°ã®çªçŽ ååã¯èšå·R2ã§ç€ºãããããã«
眮æãããŠããŠãé眮æã®ãŸãŸã§ãã€ãŠãããã
æ¬çºæã®ç¯å²å ã«å«ãŸããèšå·R2ã®çš®ã ã®çœ®æ
åºã¯äœçŽã¢ã«ãã«ãããšãã«äœçŽã¢ã«ãã«ãäœçŽ
ã¢ã«ã³ãã·äœçŽã¢ã«ãã«ãã·ã¯ããããã«ã¡ã
ã«ãïŒâãã©ãã«ã¡ãã«ãäœçŽã¢ã«ãã«
ãåŒãåºåã³åœæè¡ã§ç¥ãããŠããåçç©ã§
ãããèšå·R3åã³R4ã¯æ°ŽçŽ åã¯äœçŽã¢ã«ãã«åº
ãè¡šãããâäœçŽã¢ã«ãã«åã¯ïŒ®ïŒïŒ®âãžäœçŽ
ã¢ã«ãã«çœ®æããããã®ã®ããããã§ããåŸãã
ïŒïŒ®âãžäœçŽã¢ã«ãã«åºã¯åãäœçŽã¢ã«ãã«åº
ã§çœ®æããããåã¯æ··åäœçŽã¢ã«ãã«åºã§çœ®æã
ããŠãããã æ¬æ现æžã§äœ¿çšããäœçŽã¢ã«ãã«ãšããçšèªã¯
ïŒãïŒåã®ççŽ ååãæããåçŽãªäœçŽã¢ã«ãã«
åºäŸãã°ã¡ãã«ããšãã«ããããã«ãã€ãœããã
ã«ãããã«ãã€ãœããã«ãåã¯ïœâããã«åºã§ã
ããããšãã«äœçŽã¢ã«ãã«ãšããè¡šçŸã¯ïŒïŒïŒâ
ãªããµãžç°çªçŽ ãäœçŽã¢ã«ãã«åºã§çœ®æãããŠã
ãŠããããããšãã«åºã§çµã€ãŠãããã®äŸãã°ã
ã³ãžã«ãããšããã«ãããšãã«ãããã«ãããšã
ã«ããã«çã§ããã äœçŽã¢ã«ã³ãã·äœçŽã¢ã«ãã«ãšããçšèªã¯ïŒïŒ
ïŒâãªããµãžã³ç°çªçŽ ãäœçŽã¢ã«ãã«åºã§çœ®æã
ããŠããŠããããäœçŽã¢ã«ãã«ãšãŒãã«ã§çµã€ãŠ
ãããã®ãäŸãã°ïŒâã¡ããã·ãšãã«ãïŒâãšã
ãã·ãããã«ãåã³ïŒâããããã·ããã«åºãè¡š
ããã æ¬æ现æžã§äœ¿çšããäœçŽã¢ã«ãã«
ãè¡šãããâäœçŽã¢ã«ãã«åã¯ïŒ®ïŒïŒ®âãžäœçŽ
ã¢ã«ãã«çœ®æããããã®ã®ããããã§ããåŸãã
ïŒïŒ®âãžäœçŽã¢ã«ãã«åºã¯åãäœçŽã¢ã«ãã«åº
ã§çœ®æããããåã¯æ··åäœçŽã¢ã«ãã«åºã§çœ®æã
ããŠãããã æ¬æ现æžã§äœ¿çšããäœçŽã¢ã«ãã«ãšããçšèªã¯
ïŒãïŒåã®ççŽ ååãæããåçŽãªäœçŽã¢ã«ãã«
åºäŸãã°ã¡ãã«ããšãã«ããããã«ãã€ãœããã
ã«ãããã«ãã€ãœããã«ãåã¯ïœâããã«åºã§ã
ããããšãã«äœçŽã¢ã«ãã«ãšããè¡šçŸã¯ïŒïŒïŒâ
ãªããµãžç°çªçŽ ãäœçŽã¢ã«ãã«åºã§çœ®æãããŠã
ãŠããããããšãã«åºã§çµã€ãŠãããã®äŸãã°ã
ã³ãžã«ãããšããã«ãããšãã«ãããã«ãããšã
ã«ããã«çã§ããã äœçŽã¢ã«ã³ãã·äœçŽã¢ã«ãã«ãšããçšèªã¯ïŒïŒ
ïŒâãªããµãžã³ç°çªçŽ ãäœçŽã¢ã«ãã«åºã§çœ®æã
ããŠããŠããããäœçŽã¢ã«ãã«ãšãŒãã«ã§çµã€ãŠ
ãããã®ãäŸãã°ïŒâã¡ããã·ãšãã«ãïŒâãšã
ãã·ãããã«ãåã³ïŒâããããã·ããã«åºãè¡š
ããã æ¬æ现æžã§äœ¿çšããäœçŽã¢ã«ãã«
ãåŒããš
ããçšèªã¯ïŒïŒïŒâãªããµãžç°çªçŽ ã«çµåããŠã
ãŠã第ïŒçŽã第ïŒçŽåã¯ç¬¬ïŒçŽã¢ãã³ã®ãããã
ã§çµã€ãŠããäœçŽã¢ã«ãã«åºã§ããããã®æ§ãªåº
ã®äŸã¯ããšã¿ããã³ãïŒâãããããã³ãâãš
ãã«âãšã¿ããã³ãïŒïŒ®âãžã¡ãã«âãšã¿ãã
ã³ãåã¯ïŒ®âã¡ãã«ââãããã«âïŒâããã
ããã³åºã§ããã 補è¬äžåãå ¥ããããå¡©ãšããçšèªã¯æ¬çºæã®
ç®çã«å¯Ÿããäžèšã¢ãã³ã«çããç¡æ¯æ§ã®ææ©å
ã¯ç¡æ©ã®é žä»å å¡©ããããé©åœãªå¡©ã圢æãã代
è¡šçãªç¡æ©é žã¯å¡©é žãèåæ°ŽçŽ é žãç¡«é žåã³ç
é žã䞊ã³ã«é žéå±å¡©äŸãã°ãªã«ãçé žïŒæ°ŽçŽ ãã
ãªãŠã ãåã³ç¡«é žæ°ŽçŽ ã«ãªãŠã ã§ãããé©åœãªå¡©
ã圢æããææ©é žã®äŸã«ã¯ãã¢ãããžãåã³ããª
ã«ã«ãã³é žãäŸãã°é ¢é žããããŒã«é žããªã³ãŽ
é žãé ç³é žãã¯ãšã³é žãã¢ã¹ã³ã«ãã³é žããã¬ã€
ã³é žãããããã·ãã¬ã€ã³é žãå®æ¯éŠé žãããã
ãã·å®æ¯éŠé žãããšãã«é ¢é žãã±ã€ãé žããµãªã
ã«é žãïŒâããšããã·å®æ¯éŠé žãã¹ã«ãã³é žäŸã
ã°ã¡ã¿ã³ã¹ã«ãã³é žåã³ïŒâããããã·ãšã¿ã³ã¹
ã«ãã³é žãå«ãŸãããã¢ãåã¯ãžé žå¡©ã圢æåºæ¥
ããããã®æ§ãªå¡©ã¯æ°Žååã¯å®è³ªçã«ç¡æ°Žã®åœ¢ã®
ããããã§ååšãåŸãã æ¬çºæã«ãã€ãŠå å«ãããäŸç€ºååç©ã¯ä»¥äžã®
ãã®ãå«ãã ïŒ4aïŒ11bïŒâ10âãšãã«âïŒïŒïŒïŒ4aïŒïŒïŒ
ïŒïŒ11bâãããµãããâïŒâãããã«â2Hâ
ãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâ
ãªããµãžã³ïŒ ïŒ4aïŒ11bïŒâïŒâããã«âïŒâãã«ãªãâïŒ
âïŒïŒâãšããã·ãããã«ïŒâïŒïŒïŒïŒ4aïŒïŒïŒ
ïŒïŒ11bâãããµãããâ2HâãïŒããã³ãºãªã
ã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ïŒ ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãã
ãµãããâïŒâïŒïŒâã¡ãã«ãããã«ïŒâïŒâããš
ããã«â10âãããã«â2HâãïŒããã³ãºãªãã»
ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ïŒ ïŒ4aïŒ11bïŒâïŒâïŒïŒâãã©ãã«ã¡ãã«ïŒâïŒïŒ
ïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâïŒâãã
ãã«â2HâãïŒããã³ãºãªãã»ãããïŒïŒïŒâ
ïœãâïŒïŒïŒâãªããµãžã³ïŒ ïŒ4aïŒ11bïŒâïŒâãžã¡ãã«ã¢ãããšãã«âïŒïŒ
ïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâïŒïŒïŒâ
ãžãšãã«â2HâãïŒããã³ãºãªãã»ãããïŒïŒïŒ
âïœãâïŒïŒïŒâãªããµãžã³ïŒ ïŒ4aïŒ11bïŒâïŒâã·ã¯ããããã«ã¡ãã«âïŒïŒ
ïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâ2HâãïŒã
ãã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªã
ãµãžã³ïŒ ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãã
ãµãããâïŒïŒïŒâãžã¯ããâïŒâïŒïŒâã¡ãã«
ãããã«ïŒâ2HâãïŒããã³ãºãªãã»ãããïŒïŒ
ïŒâïœãâïŒïŒïŒâãªããµãžã³ã äžèšååç©ã¯ã·ã¹åã¯ãã©ã³ã¹é 眮ã®ãããã
ã§ããã åŒïŒïŒã®æ°èŠãªïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒ
ïŒïŒïŒïŒ11bâãããµãããâ2HâãïŒãâãã³ãº
ãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³
é¡ã¯æ¬¡ã®åå¿åŒã«èª¬æãããããã«å®¹æã«è£œé åº
æ¥ããèšå·ããR1åã³R2ã¯äžã«å®çŸ©ããéã
ã§ããã ãã®ããã«çœ®æïŒâã¢ããâïŒïŒïŒïŒïŒïŒïŒâ
ããã©ãããâïŒâãã³ãºãªãã»ãã³âïŒâãªãŒ
ã«ïŒïŒãããªãšãã«ã¢ãã³ã®æ§ãªããªã¢ã«ãã«
ã¢ãã³ã®ååšäžã«ã¯ããã¢ã»ãã«ã¯ãã©ã€ãã§ã¢
ã·ã«åããŠå¯Ÿå¿ãã眮æ2â²âã¯ããââïŒïŒïŒ
ïŒïŒïŒïŒïŒâããã©ãããâïŒâããããã·âïŒ
âãã³ãºãªãã»ãã³âïŒâã€ã«ïŒã¢ã»ãã¢ãã
ïŒïŒãçæããããšãåºæ¥ããã¢ã·ã«åã¯ã¯ã
ããã«ã åã¯å¡©åã¡ãã¬ã³ãªã©ã®äžæŽ»æ§ã®ããã²
ã³å溶åªäžã§çŽ10ããçŽ30ãã®ç¯å²ã®æž©åºŠã§å®æœåº
æ¥ãã ã¯ããã¢ã»ãã¢ããã¢ã«ã³ãŒã«ïŒïŒã¯æ°Žæ§ã¢
ã«ã³ãŒã«æº¶æ¶²äžã®åŒ·ã¢ã«ã«ãªã§ç°ååºæ¥ãããã
詳ããã¯ç°åã¯æ°Žé žåãããªãŠã ã®ã€ãœãããã
ãŒã«åã¯æ°Žæ§ã€ãœãããããŒã«äžã®æ¿åºŠæ¶²ïŒ50
ïŒ ïŒã䜿çšããŠå®€æž©ã§ïŒã24æéã§èµ·ããã ãã®æ§ã«ããŠåŸã眮æïŒ4aïŒ11bïŒâ4aïŒïŒïŒ
ïŒïŒ11bâããã©ãããâ2HâãïŒãâãã³ãºãªã
ã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³âïŒ
âïŒ4HïŒãªã³ïŒïŒã¯äžæŽ»æ§ææ©æº¶åªäžã®æ°ŽçŽ å
ç©è©Šè¬åã¯ãžãã¬ãŒãã䜿çšããŠéå ããããã
ã詳ããã¯ãæ°ŽçŽ åãªããŠã ã¢ã«ãããŠã ããã
ã©ããããã©ã³åã¯ãžãšãã«ãšãŒãã«ãªã©ã®éæµ
溶åªäžã§çŽïŒã12æé䜿çšããŠããŸãè¡ãããšã
åºæ¥ããäžã®åŒïŒïŒã§èšå·R2ãæ°ŽçŽ ãè¡šãã
ãšãã«ã¯ã眮æïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒ
ïŒïŒ11bâãããµãããâ2HâãïŒããã³ãºãªã
ã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ïŒïŒ
ãåŸãããã å¥ã®æ¹æ³ãšããŠã¯ãäžã®åŒïŒïŒã§èšå·R2ã
æ°ŽçŽ ä»¥å€ã§ãããšããçãã眮æïŒ4aïŒ11bïŒâ
ïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâ2Hâ
ãïŒãâãã³ãºãªãã»ããâãïŒïŒïŒâïœãâïŒïŒïŒ
âãªããµãžã³ïŒïŒã¯é žå¡©åç©åã¯é žç¡æ°Žç©ã§ã
ãªã¢ã«ãã«ã¢ãã³ã®ååšäžã«éœåããã¢ã·ã«åã
ãããã¢ã·ã«åã¯åã³ã¯ãããã«ã åã¯å¡©åã¡ã
ã¬ã³ãªã©ã®äžæŽ»æ§ããã²ã³å溶åªã®ååšäžã«å®æœ
ããã察å¿ãã眮æââã¢ã·ã«âïŒ4aïŒ11bïŒâ
ïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâ2Hâ
ãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâ
ãªããµãžã³ïŒïŒãäžããã ãããã®ïŒ®âã¢ã·ã«â2HâãïŒããã³ãºãªãã»
ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ïŒïŒ
ã®æ°ŽçŽ åç©åã¯ãžãã¬ãŒãè©Šè¬ã䜿çšããéå ã¯
ææã®ïŒ4aïŒ11dïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâ
ãããµãããâ2HâãïŒããã³ãºãªãã»ãã
ãïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ïŒïŒãäž
ããããã§èšå·R2ã¯æ°ŽçŽ 以å€ã®ãã®ã§ãããã
ã詳ããã¯æ°ŽçŽ åãªããŠã ã¢ã«ãããŠã ã¯ããã©
ããããã©ã³åã¯ãžãšãã«ãšãŒãã«ãªã©ã®äžæŽ»æ§
ã®éæµæº¶åªäžã§çŽïŒã12æé䜿çšããã®ãéœåã
ãã å¥ã®æ¹æ³ãšããŠã¯ãèšå·R2ãã¡ãã«åºãè¡šã
ãšãã¯ãåå¿çµè·¯ã®æçµæ®µéã§ïŒ®âã¢ã·ã«èªå°äœ
ã®ãããã«ïŒ®âã«ã«ãã³é žãšã¹ãã«ãéå ããã®
ã奜ãŸãããããããªããåŸã€ãŠã眮æïŒ4aïŒ
11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµããã
â2HâãïŒããã³ãºãªãã»ããâãïŒïŒïŒâïœãâ
ïŒïŒïŒâãªããµãžã³ïŒïŒã¯ããªã¢ã«ãã«ã¢ãã³
åã³ã¯ãããã«ã ãå¡©åã¡ãã¬ã³çã®æº¶åªã®ååš
äžã§ã¢ã«ãã«ã¯ãããã«ã¡ãŒããšåå¿ããã察å¿
ãã眮æïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11b
âãããµãããâïŒâã«ã«ãã¢ã«ã³ãã·â2Hâ
ãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâ
ãªããµãžã³èªå°äœïŒïŒäžè¬åŒ ãäžããã âã¢ã·ã«âïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒ
ïŒïŒ11bâãããµãããâ2HâãïŒããã³ãºãªã
ã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ïŒïŒ
ã®éå ã«å¯Ÿããæé ãšæ¬è³ªçã«åãæé ã䜿ã€
ãŠããã®ïŒâã«ã«ãã¢ã«ã³ãã·èªå°äœãæ°ŽçŽ åç©
åã¯ãžãã¬ãŒãè©Šè¬ã§éå ãããšææã®ïŒâã¡ã
ã«èªå°äœãäžããã äžéäœã®ïŒâã¢ããâïŒïŒïŒïŒïŒïŒïŒâããã©
ããããã³ãºãªãã»ãã³âïŒâãªãŒã«ååç©
ïŒïŒããã®ã·ã¹åã¯ãã©ã³ã¹å¹Ÿäœç°æ§äœåœ¢ã§å
åšåºæ¥ãåã ããžã¢ã¹ãã¬ãªããŒå¡©åœ¢æã«ãããª
ã©ããŠæè¡ã§ç¥ãããæ¹æ³ã«ãã€ãŠåã ã®ãšãã³
ããªããŒã«åé¢ã§ãããšãã³ããªããŒæ··åç©ã§ã
ãããšã«æ³šç®ãã¹ãã§ãããå¥æ³ãšããŠãåãšã
ã³ããªããŒã¯å åŠçã«çŽç²ãªåºçºç©è³ªããåæã
ãããšãåºæ¥ãããã¹ãŠãã®æ§ãªç°æ§äœã¯æ¬æ现
æžã§å å«ãããããæ¬æ现æžãéããŠãæ¬çºæã®
ååç©ïŒïŒã®æçµçšéã®ç¹ãããã©ã³ã¹ç°æ§äœ
ã䜿çšããã®ã奜ãŸããã åºçºç©è³ªãšããŠæçšãªçœ®æïŒâã¢ããâïŒïŒ
ïŒïŒïŒïŒïŒâããã©ãããâïŒâãã³ãºãªãã»ã
ã³âïŒâãªãŒã«ååç©ïŒïŒã¯æ¢ç¥ã®ååç©ã§ã
ãããåã¯æ¬¡ã®åå¿åŒã«åŸã€ãŠæ¢ç¥ã®ããšããŒã«
åã¯çœ®æããšããŒã«ãã容æã«è£œé åºæ¥ãååç©
ã§ããã åŸã€ãŠããšããŒã«åã¯çœ®æããšããŒã«ïŒïŒã¯
察å¿ãããããªãŠã ããšãã©ãŒããããéå°ã®ã
ããã©ã¯ãã³ãšçŽ150ã155âã®æž©åºŠã§å ç±ããã
ãšã«ãã€ãŠå¯Ÿå¿ããããšãã«ãªãã·é ªé žïŒïŒã«
å€æãããããããã®ããšãã«ãªãã·é ªé žã¯çŽ55
ã100âã®æž©åºŠã§ããªçé žãšå ç±ããããšã«ãã€
ãŠç°åãã察å¿ããïŒïŒïŒïŒïŒïŒïŒâããã©ãã
ãâïŒâãã³ãºãªãã»ãã³âïŒâãªã³ïŒXIïŒãç
æããããšãåºæ¥ãããã®æ§ã«ããŠåŸãïŒïŒïŒïŒ
ïŒïŒïŒâããã©ãããâïŒâãã³ãºãªãã»ãã³â
ïŒâãªã³ïŒXIïŒã¯ãšã¿ããŒã«äžã®ãããªãŠã ãšã
ãã·ã溶液ã«æº¶è§£ããã氷济枩床ã§ã€ãœã¢ãã«ã
ããªã«ã§åŠçãããŠïŒïŒïŒïŒïŒïŒïŒâããã©ãã
ãâïŒâãã³ãºãªãã»ãã³âïŒïŒïŒâãžãªã³âïŒ
âãªãã·ã ïŒXIIïŒãçæããã ãã®ããæ¹ã§åŸããªãã·ã ã±ãã³ïŒXIIïŒã¯é ¢
é žïŒç¡æ°Žé ¢é žæ··åç©äžã§çŽ50ã65âã®æž©åºŠã§äºé
æ«ã§éå åºæ¥ã察å¿ããïŒïŒïŒïŒïŒïŒïŒâããã©
ãããâïŒâã¢ã»ãã¢ããâïŒâãã³ãºãªãã»ã
ã³âïŒâãªã³ïŒïŒãçæããããããã®åå
ç©ããšã¿ããŒã«äžã®æ°ŽçŽ åããŠçŽ ãããªãŠã ã«ã
ã€ãŠæŽã«çŽ10ã30âã®ç¯å²ã®æž©åºŠã§éå ãããšå¯Ÿ
å¿ããã·ã¹âåã³ãã©ã³ã¹âïŒïŒïŒïŒïŒïŒïŒâã
ãã©ãããâïŒâã¢ã»ãã¢ããâïŒâãã³ãºãªã
ã»ãã³âïŒâãªãŒã«ïŒïŒã®æ··åç©ã®çæãç
ããããã®æ··åç©ãé ¢é žãšãã«åã¯ã¢ã»ããããª
ã«ãªã©ã®æº¶åªããåçµæ¶ãããšææã®ãã©ã³ã¹ç°
æ§äœã®åé¢ãçããããšã¿ããŒã«äžã®éæµããŠã
ãæ°Žé žåãããªãŠã 氎溶液ã«ãã€ãŠãããã®ç°æ§
äœïŒïŒãå æ°Žå解ãããšæ¬çºæã®ååç©ã®èª¿
補ã®åºçºç©è³ªãšããŠæçšãªææã®ïŒâã¢ããâ
ïŒïŒïŒïŒïŒïŒïŒâããã©ãããâïŒâãã³ãºãªã
ã»ãã³âïŒâãªãŒã«ïŒïŒã®ã·ã¹åã¯ãã©ã³ã¹
ïŒåã¯ãããã®æ··åç©ïŒç°æ§äœãäžããã æ¬çºæã®ååç©ã¯ããããã¢ã«ãã€ã³èªå°ã¹ã
ã©ãŠãã®å°Ÿã«å¯Ÿãããããã®æ®ææ§ã«ãã€ãŠå®èšŒ
ãããéªšæ Œçã®ç·åŒµãæžå°ããïŒã±ãŒãªãŒãšãªã¹
åã³ãžãšãŒãšã㌠ã«âãã³ã¿ãŒãããŠãŒããã¢
ãŒãã³ããžãŒã13ã211ã14ïŒ1974ïŒãæŽã«æ¬çºæ
ã®ååç©ã¯æçšãªçèåŒç·©æŽ»æ§ãæãããããã®
ååç©ã®ç°ãªã掻æ§ã«åŸã€ãŠé©åœãªæäžéã®èª¿ç¯
ã«ååé æ ®ããŠããžã¢ãŒãã åã¯ã¡ããšãã·ã³ãª
ã©ã®æ¢ç¥ã®çèåŒç·©å€ãšåãæ¹æ³ã§æž©è¡åç©ãåŠ
眮ããã®ã«äœ¿çšããããšãåºæ¥ãã æŽã«æ¬çºæã®ååç©ã¯ãããŒãšãŒãã€ããã«ã
Brit.J.Pharmacol.22ã2246ïŒ1964ïŒã«èšèŒããã
ããã«é®ç掻æ§ã«å¯ŸãããèŠæ¶çåãè©Šéšã«ãã€
ãŠæž¬å®ãããæž©è¡åç©äžã®çã¿ãçŽãã®ã«æçšã§
ããããšãããã€ãŠããã çèåŒç·©å€åã¯é®çå€ãšããŠã®æçµçšéã«æŒãŠ
ã¯æã奜ãŸããã¯ååç©ã¯ãã©ã³ã¹ç°æ§äœåœ¢ã§äœ¿
çšããããã奜ãŸãã圢æ ã®æäžãã·ã¹åœ¢ã®ã©ã
ãªãã®ããªãããšãå¿ é ãšããããã§ã¯ãªãã æ¬æ现æžã§æž©è¡åç©ãšããçšèªã¯ããŠã¹ãã©ã
ããã¢ã«ã¢ãããããããããã¡ãç«ãç¬ãçã
銬ã人ãå«ãéé·é¡ãå«ãã ååç©æäžã¯éèå ãçèå åã¯è ¹è å 泚å°ãª
ã©ã«ããéçµå£çµè·¯ã«ãã€ãŠå®æœåºæ¥ããå¥ã®æ¹
æ³ãšããŠã¯ãæ¬æ现æžã«é瀺ã®ååç©ã¯çµå£æäž
ã«ãã€ãŠè žç®¡ã«å°å ¥åºæ¥ãããã§è¡æ¶²ã®æµãã«åž
åããããå¥ã®æ¹æ³ãšããŠã¯ããããã®ååç©ã¯
ååç©ãå¿ èŠãšããåºä¹³é¡ã«ã¹ãã¬ãŒã®åœ¢æ ã§è¬
ç©ã®æº¶æ¶²ãåžåãããªã©æ°ç®¡å æäžã«ãã€ãŠå°å ¥
ãããã æå¹çèåŒç·©åã¯é®çéã¯å¿ èŠãšããæ£è ã®éªš
æ Œçã®ç·åŒµãæžå°ããåã¯é®çå¿çããªãã«åå
ãªè¬ç©éã§ããã䜿çšãããååç©ã®åã ã®éã¯
æäžã®æ¹æ³ãé »åºŠã䜿çšãããååç©åã¯åã ã®
補è¬äžåãå ¥ããããå¡©ã䞊ã³ã«åŠçœ®ããã¹ãé«
è¡å§ã®çšåºŠã®ã»ãåŠçãããã¹ãåºä¹³é¡ã®å¯žæ³ã
çš®é¡ãæ§ãåã³å¹Žä»€ãªã©ã®çš®ã ã®èŠå ã«äŸåããŠ
åºãå€åãããç¹å®ã®å Žåã«ã¯æäžãããã¹ãæ
äžéã¯æ £çšã®ç¯å²å²åºãæè¡äŸãã°çš®ã ã®æäžæ°Ž
æºã«æŒããè¡å§æžå°ã®è¿œè·¡ã«ãã€ãŠæ±ºå®åºæ¥ãã æ¬æ现æžã«èšèŒããååç©ã¯çŽïŒmgãªããçŽ
3000mgã®ç¯å²ã«2HâãïŒããã³ãºãªãã»ãã
ãïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³èªå°äœã®æäž
éã§æäžåºæ¥ãïŒæ¥ïŒãïŒåæäžåºæ¥ãããã詳
ããã¯ãåç©äœéããã°ã©ã åœããçŽïŒãªããçŽ
20ããªã°ã©ã çµå£æäžéã䜿çšããããšãåºæ¥
ããåç©äœéããã°ã©ã åœããçŽ0.1mgãªããçŽ
10ããªã°ã©ã ã®ããäœãéçµå£æäžéãéœåãã
䜿çšããããšãåºæ¥ãã åäœæäžåœ¢ã®æ¬çºæã®ååç©ãæäžããã®ãäž
è¬ã«æãŸãããåäœæäžåœ¢ã¯çŽïŒã500mgã®æŽ»æ§
æåã奜ãŸããã¯ïŒã150mgã®æŽ»æ§æåãå«æåº
æ¥ãïŒæïŒåã¯ãã以äžã®åæ°ãšãããšãåºæ¥
ããçµå£æäžã«é©ããæè¬åäœã«ã¯é å€ãã«ãã»
ã«å€ãããŒã³ãžå€ããšãªãã·ã«ãã·ããããªã©ã
å«ãŸããã 掻æ§ååç©ã¯æ £çšã®æé ã«ãã€ãŠãåã¯ã¿ã€ã
ã³ã°ãããããæŸåºã«ãã»ã«ãšããŠãåã¯ãã®æ
è¡ã«çéããè ã«è¯ãç¥ãããæè¡ã䜿ã€ãé å€
åŠæ¹ãšããŠåŠæ¹åºæ¥ããè¿ éãªäœçšãæãŸãããš
ãã¯ã掻æ§æåã¯æ³šå°å¯èœãªçµæç©ãã¹ãã¬ãŒã
åã¯åžåŒçæ³ã®ããã®ãšããŸã«ãšããŠåŠæ¹åºæ¥
ãã æ¬çºæã®å®æœã«æŒãŠã掻æ§æåã¯çŽïŒãçŽ90é
éããŒã»ã³ãã®æäžãæ±ããããŠããç²ç¶ã®2H
âãïŒãâãã³ãºãªãã»ããâãïŒïŒïŒâïœãâïŒïŒ
ïŒâãªããµãžã³åã¯è£œè¬äžåãå ¥ãããããã®å¡©
ã補è¬æ äœãšçµã¿åãããŠå«ãçµæç©ãšããŠåŠæ¹
ãããã®ã奜ãŸããã 補è¬æ äœãšããçšèªã¯ç¡æ¯æ§ã§è£œè¬çµæç©ã®åŠ
æ¹äžã«æçšãªãã®æè¡ã§ç¥ãããŠãã補è¬è³Šåœ¢å€
ã§ããããã®æ§ãªçµæç©ã¯é å€ãã«ãã»ã«å€ãã
ãŒã³ãžããããŒãã座è¬ããšã«ãã·ã«ãã·ãã
ãããšãã«ãžãšã³ãåæ£æ¶²ãæ°Žååã³æ³¡ç«ãŠç²
æ«ãæ» è泚å°çµæç©åã³ã¹ãã¬ãŒçšæº¶æ¶²ã®èª¿è£œã§
ãã®æè¡åéã§ç¥ãããŠããæè¡ãã€ãã€ãŠèª¿è£œ
åºæ¥ãæãŸããçµæã®åã ã®åœ¢åŒã®èª¿è£œã§æçšã§
ããããšãç¥ãããŠããé©åœãªè³Šåœ¢è¬ãå«ã¿åŸ
ãã é©åœãªè£œè¬æ äœåã³åŠæ¹æè¡ã¯ã¬ãã³ãã³ãºã
ã¢ãŒãã¹ãŒãã€ã«ã« ãµã€ãšã³ã¹16çïŒ1980ïŒã¡
ã«ã¯ ãããªãã·ã³ã° ã«ã³ãã㌠ãã³ã·ã«ã
ãã¢å·ã€ãŒã¹ãããªã©ã®æšæºããã¹ãã«èšèŒãã
ãŠããã 次ã®å®æœäŸã¯æ¬çºæãæŽã«èª¬æããããããã
ãã«ãæ¬çºæãéå®ãããã®ãšã¯è§£éãããã¹ã
ã§ãªãã å®æœäŸ ïŒ ãã©ã³ã¹âïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ
11bâãããµãããâ2HâãïŒããã³ãºãªãã»
ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³å¡©é ž
å¡© 400mlã®ã¯ãããã«ã äžã®8.07ïœã®ãã©ã³ã¹â
ïŒâã¢ããâïŒïŒïŒïŒïŒïŒïŒâããã©ãããâïŒ
âãã³ãºãªãã»ãã³âïŒâãªãŒã«åã³ïŒmlã®ããª
ãšãã«ã¢ãã³ã®æº¶æ¶²ã50mlã®ã¯ãããã«ã äžã®
5.58mgã®ã¯ããã¢ã»ãã«ã¯ãã©ã€ãã®æº¶æ¶²ããã€
ããå ãããæ··åç©ã宀枩ã§äžå€æŸçœ®ããåžå¡©é ž
溶液ã§æŽããç¡«é žãã°ãã·ãŠã ã®åºãéããŠãé
ãããã液ã®èžçºåã³ãã«ãšã³ããã®æ®æž£ã®åçµ
æ¶åã«ãã8.43ïœã®ãã©ã³ã¹â2â²âã¯ããââ
ïŒïŒïŒïŒïŒïŒïŒïŒâããã©ãããâïŒâãããã
ã·âïŒâãã³ãºãªãã»ãã³âïŒâã€ã«ïŒã¢ã»ãã¢
ãããçæããã ããã¯èç¹141ãïŒâãæããã 460mlã®ã€ãœãããããŒã«äžã«æº¶è§£ãã8.3ïœã®
äžã®ã¢ããã®æº¶æ¶²ã7.2ïœã50ïŒ æ°Žé žåãããªãŠ
ã 氎溶液ã§åŠçããŠãæ··åç©ã宀枩ã§äžå€æ¹æã
ãã溶åªãæ¿çž®ããæ°Žã§åžéãããçæããäžæº¶
ç©ããéããŠé€ããã¢ã»ããããªã«ã§åçµæ¶ãã
ãš4.31ïœã®ãã©ã³ã¹âïŒ4aïŒ11bïŒâ4aïŒïŒïŒïŒïŒ
11bâããã©ãããâ2HâãïŒããã³ãºãªãã»ã
ããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³âïŒïŒ4HïŒ
ãªã³ãçæããã ããã¯èç¹246ãïŒâãæããã 100mlã®ããã©ããããã©ã³äžã®1.5ïœã®æ°ŽçŽ å
ãªããŠã ã¢ã«ãããŠã ã®æžæ¿æ¶²ã«æ»Žäžã«ãã4.18
ïœã®ïŒ4aïŒ11bïŒâ4aïŒïŒïŒïŒïŒ11bâããã©ãã
ãâ2HâãïŒããã³ãºãªãã»ããâãïŒïŒïŒâïœã
âïŒïŒïŒâãªããµãžã³âïŒïŒ4HïŒãªã³ãå ããã
æ··åç©ãïŒæééæµããæ°·äžã§å·ãããéå°ã®æ°Ž
çŽ åç©ãïŒmlã®10ïŒ æ°Žé žåãããªãŠã 溶液添å ã«
ãã€ãŠå解ãããçããæ··åç©ãäžå€æ¹æããåº
äœããéããŠé€ãã溶åªãèžçºã«ããé€ããæ®ç
ç©ããšãŒãã«äžã«æº¶è§£ãããšãŒãã«æ§ã®å¡©åæ°ŽçŽ
ã§åŠçãããæ²æ®¿ããè¡šé¡ååç©ãã¡ã¿ããŒã«ïŒ
ã¢ã»ããããªã«æº¶æ¶²ããåçµæ¶ããŠ2.69ïœã®ç©è³ª
ãçæããã ããã¯èç¹259ã60âãæããã æ¬è³ªçã«åãæé ã«åŸããã次ã®ãã©ã³ã¹âïŒ
âã¢ããâïŒïŒïŒïŒïŒïŒïŒâããã©ãããâïŒâ
ãã³ãºãªãã»ãã³âïŒâãªãŒã«ããããŠã次ã®ä»¥
äžã«ç€ºãçæç©ãçæããã
ãŠã第ïŒçŽã第ïŒçŽåã¯ç¬¬ïŒçŽã¢ãã³ã®ãããã
ã§çµã€ãŠããäœçŽã¢ã«ãã«åºã§ããããã®æ§ãªåº
ã®äŸã¯ããšã¿ããã³ãïŒâãããããã³ãâãš
ãã«âãšã¿ããã³ãïŒïŒ®âãžã¡ãã«âãšã¿ãã
ã³ãåã¯ïŒ®âã¡ãã«ââãããã«âïŒâããã
ããã³åºã§ããã 補è¬äžåãå ¥ããããå¡©ãšããçšèªã¯æ¬çºæã®
ç®çã«å¯Ÿããäžèšã¢ãã³ã«çããç¡æ¯æ§ã®ææ©å
ã¯ç¡æ©ã®é žä»å å¡©ããããé©åœãªå¡©ã圢æãã代
è¡šçãªç¡æ©é žã¯å¡©é žãèåæ°ŽçŽ é žãç¡«é žåã³ç
é žã䞊ã³ã«é žéå±å¡©äŸãã°ãªã«ãçé žïŒæ°ŽçŽ ãã
ãªãŠã ãåã³ç¡«é žæ°ŽçŽ ã«ãªãŠã ã§ãããé©åœãªå¡©
ã圢æããææ©é žã®äŸã«ã¯ãã¢ãããžãåã³ããª
ã«ã«ãã³é žãäŸãã°é ¢é žããããŒã«é žããªã³ãŽ
é žãé ç³é žãã¯ãšã³é žãã¢ã¹ã³ã«ãã³é žããã¬ã€
ã³é žãããããã·ãã¬ã€ã³é žãå®æ¯éŠé žãããã
ãã·å®æ¯éŠé žãããšãã«é ¢é žãã±ã€ãé žããµãªã
ã«é žãïŒâããšããã·å®æ¯éŠé žãã¹ã«ãã³é žäŸã
ã°ã¡ã¿ã³ã¹ã«ãã³é žåã³ïŒâããããã·ãšã¿ã³ã¹
ã«ãã³é žãå«ãŸãããã¢ãåã¯ãžé žå¡©ã圢æåºæ¥
ããããã®æ§ãªå¡©ã¯æ°Žååã¯å®è³ªçã«ç¡æ°Žã®åœ¢ã®
ããããã§ååšãåŸãã æ¬çºæã«ãã€ãŠå å«ãããäŸç€ºååç©ã¯ä»¥äžã®
ãã®ãå«ãã ïŒ4aïŒ11bïŒâ10âãšãã«âïŒïŒïŒïŒ4aïŒïŒïŒ
ïŒïŒ11bâãããµãããâïŒâãããã«â2Hâ
ãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâ
ãªããµãžã³ïŒ ïŒ4aïŒ11bïŒâïŒâããã«âïŒâãã«ãªãâïŒ
âïŒïŒâãšããã·ãããã«ïŒâïŒïŒïŒïŒ4aïŒïŒïŒ
ïŒïŒ11bâãããµãããâ2HâãïŒããã³ãºãªã
ã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ïŒ ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãã
ãµãããâïŒâïŒïŒâã¡ãã«ãããã«ïŒâïŒâããš
ããã«â10âãããã«â2HâãïŒããã³ãºãªãã»
ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ïŒ ïŒ4aïŒ11bïŒâïŒâïŒïŒâãã©ãã«ã¡ãã«ïŒâïŒïŒ
ïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâïŒâãã
ãã«â2HâãïŒããã³ãºãªãã»ãããïŒïŒïŒâ
ïœãâïŒïŒïŒâãªããµãžã³ïŒ ïŒ4aïŒ11bïŒâïŒâãžã¡ãã«ã¢ãããšãã«âïŒïŒ
ïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâïŒïŒïŒâ
ãžãšãã«â2HâãïŒããã³ãºãªãã»ãããïŒïŒïŒ
âïœãâïŒïŒïŒâãªããµãžã³ïŒ ïŒ4aïŒ11bïŒâïŒâã·ã¯ããããã«ã¡ãã«âïŒïŒ
ïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâ2HâãïŒã
ãã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªã
ãµãžã³ïŒ ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãã
ãµãããâïŒïŒïŒâãžã¯ããâïŒâïŒïŒâã¡ãã«
ãããã«ïŒâ2HâãïŒããã³ãºãªãã»ãããïŒïŒ
ïŒâïœãâïŒïŒïŒâãªããµãžã³ã äžèšååç©ã¯ã·ã¹åã¯ãã©ã³ã¹é 眮ã®ãããã
ã§ããã åŒïŒïŒã®æ°èŠãªïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒ
ïŒïŒïŒïŒ11bâãããµãããâ2HâãïŒãâãã³ãº
ãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³
é¡ã¯æ¬¡ã®åå¿åŒã«èª¬æãããããã«å®¹æã«è£œé åº
æ¥ããèšå·ããR1åã³R2ã¯äžã«å®çŸ©ããéã
ã§ããã ãã®ããã«çœ®æïŒâã¢ããâïŒïŒïŒïŒïŒïŒïŒâ
ããã©ãããâïŒâãã³ãºãªãã»ãã³âïŒâãªãŒ
ã«ïŒïŒãããªãšãã«ã¢ãã³ã®æ§ãªããªã¢ã«ãã«
ã¢ãã³ã®ååšäžã«ã¯ããã¢ã»ãã«ã¯ãã©ã€ãã§ã¢
ã·ã«åããŠå¯Ÿå¿ãã眮æ2â²âã¯ããââïŒïŒïŒ
ïŒïŒïŒïŒïŒâããã©ãããâïŒâããããã·âïŒ
âãã³ãºãªãã»ãã³âïŒâã€ã«ïŒã¢ã»ãã¢ãã
ïŒïŒãçæããããšãåºæ¥ããã¢ã·ã«åã¯ã¯ã
ããã«ã åã¯å¡©åã¡ãã¬ã³ãªã©ã®äžæŽ»æ§ã®ããã²
ã³å溶åªäžã§çŽ10ããçŽ30ãã®ç¯å²ã®æž©åºŠã§å®æœåº
æ¥ãã ã¯ããã¢ã»ãã¢ããã¢ã«ã³ãŒã«ïŒïŒã¯æ°Žæ§ã¢
ã«ã³ãŒã«æº¶æ¶²äžã®åŒ·ã¢ã«ã«ãªã§ç°ååºæ¥ãããã
詳ããã¯ç°åã¯æ°Žé žåãããªãŠã ã®ã€ãœãããã
ãŒã«åã¯æ°Žæ§ã€ãœãããããŒã«äžã®æ¿åºŠæ¶²ïŒ50
ïŒ ïŒã䜿çšããŠå®€æž©ã§ïŒã24æéã§èµ·ããã ãã®æ§ã«ããŠåŸã眮æïŒ4aïŒ11bïŒâ4aïŒïŒïŒ
ïŒïŒ11bâããã©ãããâ2HâãïŒãâãã³ãºãªã
ã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³âïŒ
âïŒ4HïŒãªã³ïŒïŒã¯äžæŽ»æ§ææ©æº¶åªäžã®æ°ŽçŽ å
ç©è©Šè¬åã¯ãžãã¬ãŒãã䜿çšããŠéå ããããã
ã詳ããã¯ãæ°ŽçŽ åãªããŠã ã¢ã«ãããŠã ããã
ã©ããããã©ã³åã¯ãžãšãã«ãšãŒãã«ãªã©ã®éæµ
溶åªäžã§çŽïŒã12æé䜿çšããŠããŸãè¡ãããšã
åºæ¥ããäžã®åŒïŒïŒã§èšå·R2ãæ°ŽçŽ ãè¡šãã
ãšãã«ã¯ã眮æïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒ
ïŒïŒ11bâãããµãããâ2HâãïŒããã³ãºãªã
ã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ïŒïŒ
ãåŸãããã å¥ã®æ¹æ³ãšããŠã¯ãäžã®åŒïŒïŒã§èšå·R2ã
æ°ŽçŽ ä»¥å€ã§ãããšããçãã眮æïŒ4aïŒ11bïŒâ
ïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâ2Hâ
ãïŒãâãã³ãºãªãã»ããâãïŒïŒïŒâïœãâïŒïŒïŒ
âãªããµãžã³ïŒïŒã¯é žå¡©åç©åã¯é žç¡æ°Žç©ã§ã
ãªã¢ã«ãã«ã¢ãã³ã®ååšäžã«éœåããã¢ã·ã«åã
ãããã¢ã·ã«åã¯åã³ã¯ãããã«ã åã¯å¡©åã¡ã
ã¬ã³ãªã©ã®äžæŽ»æ§ããã²ã³å溶åªã®ååšäžã«å®æœ
ããã察å¿ãã眮æââã¢ã·ã«âïŒ4aïŒ11bïŒâ
ïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâ2Hâ
ãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâ
ãªããµãžã³ïŒïŒãäžããã ãããã®ïŒ®âã¢ã·ã«â2HâãïŒããã³ãºãªãã»
ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ïŒïŒ
ã®æ°ŽçŽ åç©åã¯ãžãã¬ãŒãè©Šè¬ã䜿çšããéå ã¯
ææã®ïŒ4aïŒ11dïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâ
ãããµãããâ2HâãïŒããã³ãºãªãã»ãã
ãïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ïŒïŒãäž
ããããã§èšå·R2ã¯æ°ŽçŽ 以å€ã®ãã®ã§ãããã
ã詳ããã¯æ°ŽçŽ åãªããŠã ã¢ã«ãããŠã ã¯ããã©
ããããã©ã³åã¯ãžãšãã«ãšãŒãã«ãªã©ã®äžæŽ»æ§
ã®éæµæº¶åªäžã§çŽïŒã12æé䜿çšããã®ãéœåã
ãã å¥ã®æ¹æ³ãšããŠã¯ãèšå·R2ãã¡ãã«åºãè¡šã
ãšãã¯ãåå¿çµè·¯ã®æçµæ®µéã§ïŒ®âã¢ã·ã«èªå°äœ
ã®ãããã«ïŒ®âã«ã«ãã³é žãšã¹ãã«ãéå ããã®
ã奜ãŸãããããããªããåŸã€ãŠã眮æïŒ4aïŒ
11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµããã
â2HâãïŒããã³ãºãªãã»ããâãïŒïŒïŒâïœãâ
ïŒïŒïŒâãªããµãžã³ïŒïŒã¯ããªã¢ã«ãã«ã¢ãã³
åã³ã¯ãããã«ã ãå¡©åã¡ãã¬ã³çã®æº¶åªã®ååš
äžã§ã¢ã«ãã«ã¯ãããã«ã¡ãŒããšåå¿ããã察å¿
ãã眮æïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11b
âãããµãããâïŒâã«ã«ãã¢ã«ã³ãã·â2Hâ
ãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâ
ãªããµãžã³èªå°äœïŒïŒäžè¬åŒ ãäžããã âã¢ã·ã«âïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒ
ïŒïŒ11bâãããµãããâ2HâãïŒããã³ãºãªã
ã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ïŒïŒ
ã®éå ã«å¯Ÿããæé ãšæ¬è³ªçã«åãæé ã䜿ã€
ãŠããã®ïŒâã«ã«ãã¢ã«ã³ãã·èªå°äœãæ°ŽçŽ åç©
åã¯ãžãã¬ãŒãè©Šè¬ã§éå ãããšææã®ïŒâã¡ã
ã«èªå°äœãäžããã äžéäœã®ïŒâã¢ããâïŒïŒïŒïŒïŒïŒïŒâããã©
ããããã³ãºãªãã»ãã³âïŒâãªãŒã«ååç©
ïŒïŒããã®ã·ã¹åã¯ãã©ã³ã¹å¹Ÿäœç°æ§äœåœ¢ã§å
åšåºæ¥ãåã ããžã¢ã¹ãã¬ãªããŒå¡©åœ¢æã«ãããª
ã©ããŠæè¡ã§ç¥ãããæ¹æ³ã«ãã€ãŠåã ã®ãšãã³
ããªããŒã«åé¢ã§ãããšãã³ããªããŒæ··åç©ã§ã
ãããšã«æ³šç®ãã¹ãã§ãããå¥æ³ãšããŠãåãšã
ã³ããªããŒã¯å åŠçã«çŽç²ãªåºçºç©è³ªããåæã
ãããšãåºæ¥ãããã¹ãŠãã®æ§ãªç°æ§äœã¯æ¬æ现
æžã§å å«ãããããæ¬æ现æžãéããŠãæ¬çºæã®
ååç©ïŒïŒã®æçµçšéã®ç¹ãããã©ã³ã¹ç°æ§äœ
ã䜿çšããã®ã奜ãŸããã åºçºç©è³ªãšããŠæçšãªçœ®æïŒâã¢ããâïŒïŒ
ïŒïŒïŒïŒïŒâããã©ãããâïŒâãã³ãºãªãã»ã
ã³âïŒâãªãŒã«ååç©ïŒïŒã¯æ¢ç¥ã®ååç©ã§ã
ãããåã¯æ¬¡ã®åå¿åŒã«åŸã€ãŠæ¢ç¥ã®ããšããŒã«
åã¯çœ®æããšããŒã«ãã容æã«è£œé åºæ¥ãååç©
ã§ããã åŸã€ãŠããšããŒã«åã¯çœ®æããšããŒã«ïŒïŒã¯
察å¿ãããããªãŠã ããšãã©ãŒããããéå°ã®ã
ããã©ã¯ãã³ãšçŽ150ã155âã®æž©åºŠã§å ç±ããã
ãšã«ãã€ãŠå¯Ÿå¿ããããšãã«ãªãã·é ªé žïŒïŒã«
å€æãããããããã®ããšãã«ãªãã·é ªé žã¯çŽ55
ã100âã®æž©åºŠã§ããªçé žãšå ç±ããããšã«ãã€
ãŠç°åãã察å¿ããïŒïŒïŒïŒïŒïŒïŒâããã©ãã
ãâïŒâãã³ãºãªãã»ãã³âïŒâãªã³ïŒXIïŒãç
æããããšãåºæ¥ãããã®æ§ã«ããŠåŸãïŒïŒïŒïŒ
ïŒïŒïŒâããã©ãããâïŒâãã³ãºãªãã»ãã³â
ïŒâãªã³ïŒXIïŒã¯ãšã¿ããŒã«äžã®ãããªãŠã ãšã
ãã·ã溶液ã«æº¶è§£ããã氷济枩床ã§ã€ãœã¢ãã«ã
ããªã«ã§åŠçãããŠïŒïŒïŒïŒïŒïŒïŒâããã©ãã
ãâïŒâãã³ãºãªãã»ãã³âïŒïŒïŒâãžãªã³âïŒ
âãªãã·ã ïŒXIIïŒãçæããã ãã®ããæ¹ã§åŸããªãã·ã ã±ãã³ïŒXIIïŒã¯é ¢
é žïŒç¡æ°Žé ¢é žæ··åç©äžã§çŽ50ã65âã®æž©åºŠã§äºé
æ«ã§éå åºæ¥ã察å¿ããïŒïŒïŒïŒïŒïŒïŒâããã©
ãããâïŒâã¢ã»ãã¢ããâïŒâãã³ãºãªãã»ã
ã³âïŒâãªã³ïŒïŒãçæããããããã®åå
ç©ããšã¿ããŒã«äžã®æ°ŽçŽ åããŠçŽ ãããªãŠã ã«ã
ã€ãŠæŽã«çŽ10ã30âã®ç¯å²ã®æž©åºŠã§éå ãããšå¯Ÿ
å¿ããã·ã¹âåã³ãã©ã³ã¹âïŒïŒïŒïŒïŒïŒïŒâã
ãã©ãããâïŒâã¢ã»ãã¢ããâïŒâãã³ãºãªã
ã»ãã³âïŒâãªãŒã«ïŒïŒã®æ··åç©ã®çæãç
ããããã®æ··åç©ãé ¢é žãšãã«åã¯ã¢ã»ããããª
ã«ãªã©ã®æº¶åªããåçµæ¶ãããšææã®ãã©ã³ã¹ç°
æ§äœã®åé¢ãçããããšã¿ããŒã«äžã®éæµããŠã
ãæ°Žé žåãããªãŠã 氎溶液ã«ãã€ãŠãããã®ç°æ§
äœïŒïŒãå æ°Žå解ãããšæ¬çºæã®ååç©ã®èª¿
補ã®åºçºç©è³ªãšããŠæçšãªææã®ïŒâã¢ããâ
ïŒïŒïŒïŒïŒïŒïŒâããã©ãããâïŒâãã³ãºãªã
ã»ãã³âïŒâãªãŒã«ïŒïŒã®ã·ã¹åã¯ãã©ã³ã¹
ïŒåã¯ãããã®æ··åç©ïŒç°æ§äœãäžããã æ¬çºæã®ååç©ã¯ããããã¢ã«ãã€ã³èªå°ã¹ã
ã©ãŠãã®å°Ÿã«å¯Ÿãããããã®æ®ææ§ã«ãã€ãŠå®èšŒ
ãããéªšæ Œçã®ç·åŒµãæžå°ããïŒã±ãŒãªãŒãšãªã¹
åã³ãžãšãŒãšã㌠ã«âãã³ã¿ãŒãããŠãŒããã¢
ãŒãã³ããžãŒã13ã211ã14ïŒ1974ïŒãæŽã«æ¬çºæ
ã®ååç©ã¯æçšãªçèåŒç·©æŽ»æ§ãæãããããã®
ååç©ã®ç°ãªã掻æ§ã«åŸã€ãŠé©åœãªæäžéã®èª¿ç¯
ã«ååé æ ®ããŠããžã¢ãŒãã åã¯ã¡ããšãã·ã³ãª
ã©ã®æ¢ç¥ã®çèåŒç·©å€ãšåãæ¹æ³ã§æž©è¡åç©ãåŠ
眮ããã®ã«äœ¿çšããããšãåºæ¥ãã æŽã«æ¬çºæã®ååç©ã¯ãããŒãšãŒãã€ããã«ã
Brit.J.Pharmacol.22ã2246ïŒ1964ïŒã«èšèŒããã
ããã«é®ç掻æ§ã«å¯ŸãããèŠæ¶çåãè©Šéšã«ãã€
ãŠæž¬å®ãããæž©è¡åç©äžã®çã¿ãçŽãã®ã«æçšã§
ããããšãããã€ãŠããã çèåŒç·©å€åã¯é®çå€ãšããŠã®æçµçšéã«æŒãŠ
ã¯æã奜ãŸããã¯ååç©ã¯ãã©ã³ã¹ç°æ§äœåœ¢ã§äœ¿
çšããããã奜ãŸãã圢æ ã®æäžãã·ã¹åœ¢ã®ã©ã
ãªãã®ããªãããšãå¿ é ãšããããã§ã¯ãªãã æ¬æ现æžã§æž©è¡åç©ãšããçšèªã¯ããŠã¹ãã©ã
ããã¢ã«ã¢ãããããããããã¡ãç«ãç¬ãçã
銬ã人ãå«ãéé·é¡ãå«ãã ååç©æäžã¯éèå ãçèå åã¯è ¹è å 泚å°ãª
ã©ã«ããéçµå£çµè·¯ã«ãã€ãŠå®æœåºæ¥ããå¥ã®æ¹
æ³ãšããŠã¯ãæ¬æ现æžã«é瀺ã®ååç©ã¯çµå£æäž
ã«ãã€ãŠè žç®¡ã«å°å ¥åºæ¥ãããã§è¡æ¶²ã®æµãã«åž
åããããå¥ã®æ¹æ³ãšããŠã¯ããããã®ååç©ã¯
ååç©ãå¿ èŠãšããåºä¹³é¡ã«ã¹ãã¬ãŒã®åœ¢æ ã§è¬
ç©ã®æº¶æ¶²ãåžåãããªã©æ°ç®¡å æäžã«ãã€ãŠå°å ¥
ãããã æå¹çèåŒç·©åã¯é®çéã¯å¿ èŠãšããæ£è ã®éªš
æ Œçã®ç·åŒµãæžå°ããåã¯é®çå¿çããªãã«åå
ãªè¬ç©éã§ããã䜿çšãããååç©ã®åã ã®éã¯
æäžã®æ¹æ³ãé »åºŠã䜿çšãããååç©åã¯åã ã®
補è¬äžåãå ¥ããããå¡©ã䞊ã³ã«åŠçœ®ããã¹ãé«
è¡å§ã®çšåºŠã®ã»ãåŠçãããã¹ãåºä¹³é¡ã®å¯žæ³ã
çš®é¡ãæ§ãåã³å¹Žä»€ãªã©ã®çš®ã ã®èŠå ã«äŸåããŠ
åºãå€åãããç¹å®ã®å Žåã«ã¯æäžãããã¹ãæ
äžéã¯æ £çšã®ç¯å²å²åºãæè¡äŸãã°çš®ã ã®æäžæ°Ž
æºã«æŒããè¡å§æžå°ã®è¿œè·¡ã«ãã€ãŠæ±ºå®åºæ¥ãã æ¬æ现æžã«èšèŒããååç©ã¯çŽïŒmgãªããçŽ
3000mgã®ç¯å²ã«2HâãïŒããã³ãºãªãã»ãã
ãïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³èªå°äœã®æäž
éã§æäžåºæ¥ãïŒæ¥ïŒãïŒåæäžåºæ¥ãããã詳
ããã¯ãåç©äœéããã°ã©ã åœããçŽïŒãªããçŽ
20ããªã°ã©ã çµå£æäžéã䜿çšããããšãåºæ¥
ããåç©äœéããã°ã©ã åœããçŽ0.1mgãªããçŽ
10ããªã°ã©ã ã®ããäœãéçµå£æäžéãéœåãã
䜿çšããããšãåºæ¥ãã åäœæäžåœ¢ã®æ¬çºæã®ååç©ãæäžããã®ãäž
è¬ã«æãŸãããåäœæäžåœ¢ã¯çŽïŒã500mgã®æŽ»æ§
æåã奜ãŸããã¯ïŒã150mgã®æŽ»æ§æåãå«æåº
æ¥ãïŒæïŒåã¯ãã以äžã®åæ°ãšãããšãåºæ¥
ããçµå£æäžã«é©ããæè¬åäœã«ã¯é å€ãã«ãã»
ã«å€ãããŒã³ãžå€ããšãªãã·ã«ãã·ããããªã©ã
å«ãŸããã 掻æ§ååç©ã¯æ £çšã®æé ã«ãã€ãŠãåã¯ã¿ã€ã
ã³ã°ãããããæŸåºã«ãã»ã«ãšããŠãåã¯ãã®æ
è¡ã«çéããè ã«è¯ãç¥ãããæè¡ã䜿ã€ãé å€
åŠæ¹ãšããŠåŠæ¹åºæ¥ããè¿ éãªäœçšãæãŸãããš
ãã¯ã掻æ§æåã¯æ³šå°å¯èœãªçµæç©ãã¹ãã¬ãŒã
åã¯åžåŒçæ³ã®ããã®ãšããŸã«ãšããŠåŠæ¹åºæ¥
ãã æ¬çºæã®å®æœã«æŒãŠã掻æ§æåã¯çŽïŒãçŽ90é
éããŒã»ã³ãã®æäžãæ±ããããŠããç²ç¶ã®2H
âãïŒãâãã³ãºãªãã»ããâãïŒïŒïŒâïœãâïŒïŒ
ïŒâãªããµãžã³åã¯è£œè¬äžåãå ¥ãããããã®å¡©
ã補è¬æ äœãšçµã¿åãããŠå«ãçµæç©ãšããŠåŠæ¹
ãããã®ã奜ãŸããã 補è¬æ äœãšããçšèªã¯ç¡æ¯æ§ã§è£œè¬çµæç©ã®åŠ
æ¹äžã«æçšãªãã®æè¡ã§ç¥ãããŠãã補è¬è³Šåœ¢å€
ã§ããããã®æ§ãªçµæç©ã¯é å€ãã«ãã»ã«å€ãã
ãŒã³ãžããããŒãã座è¬ããšã«ãã·ã«ãã·ãã
ãããšãã«ãžãšã³ãåæ£æ¶²ãæ°Žååã³æ³¡ç«ãŠç²
æ«ãæ» è泚å°çµæç©åã³ã¹ãã¬ãŒçšæº¶æ¶²ã®èª¿è£œã§
ãã®æè¡åéã§ç¥ãããŠããæè¡ãã€ãã€ãŠèª¿è£œ
åºæ¥ãæãŸããçµæã®åã ã®åœ¢åŒã®èª¿è£œã§æçšã§
ããããšãç¥ãããŠããé©åœãªè³Šåœ¢è¬ãå«ã¿åŸ
ãã é©åœãªè£œè¬æ äœåã³åŠæ¹æè¡ã¯ã¬ãã³ãã³ãºã
ã¢ãŒãã¹ãŒãã€ã«ã« ãµã€ãšã³ã¹16çïŒ1980ïŒã¡
ã«ã¯ ãããªãã·ã³ã° ã«ã³ãã㌠ãã³ã·ã«ã
ãã¢å·ã€ãŒã¹ãããªã©ã®æšæºããã¹ãã«èšèŒãã
ãŠããã 次ã®å®æœäŸã¯æ¬çºæãæŽã«èª¬æããããããã
ãã«ãæ¬çºæãéå®ãããã®ãšã¯è§£éãããã¹ã
ã§ãªãã å®æœäŸ ïŒ ãã©ã³ã¹âïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ
11bâãããµãããâ2HâãïŒããã³ãºãªãã»
ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³å¡©é ž
å¡© 400mlã®ã¯ãããã«ã äžã®8.07ïœã®ãã©ã³ã¹â
ïŒâã¢ããâïŒïŒïŒïŒïŒïŒïŒâããã©ãããâïŒ
âãã³ãºãªãã»ãã³âïŒâãªãŒã«åã³ïŒmlã®ããª
ãšãã«ã¢ãã³ã®æº¶æ¶²ã50mlã®ã¯ãããã«ã äžã®
5.58mgã®ã¯ããã¢ã»ãã«ã¯ãã©ã€ãã®æº¶æ¶²ããã€
ããå ãããæ··åç©ã宀枩ã§äžå€æŸçœ®ããåžå¡©é ž
溶液ã§æŽããç¡«é žãã°ãã·ãŠã ã®åºãéããŠãé
ãããã液ã®èžçºåã³ãã«ãšã³ããã®æ®æž£ã®åçµ
æ¶åã«ãã8.43ïœã®ãã©ã³ã¹â2â²âã¯ããââ
ïŒïŒïŒïŒïŒïŒïŒïŒâããã©ãããâïŒâãããã
ã·âïŒâãã³ãºãªãã»ãã³âïŒâã€ã«ïŒã¢ã»ãã¢
ãããçæããã ããã¯èç¹141ãïŒâãæããã 460mlã®ã€ãœãããããŒã«äžã«æº¶è§£ãã8.3ïœã®
äžã®ã¢ããã®æº¶æ¶²ã7.2ïœã50ïŒ æ°Žé žåãããªãŠ
ã 氎溶液ã§åŠçããŠãæ··åç©ã宀枩ã§äžå€æ¹æã
ãã溶åªãæ¿çž®ããæ°Žã§åžéãããçæããäžæº¶
ç©ããéããŠé€ããã¢ã»ããããªã«ã§åçµæ¶ãã
ãš4.31ïœã®ãã©ã³ã¹âïŒ4aïŒ11bïŒâ4aïŒïŒïŒïŒïŒ
11bâããã©ãããâ2HâãïŒããã³ãºãªãã»ã
ããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³âïŒïŒ4HïŒ
ãªã³ãçæããã ããã¯èç¹246ãïŒâãæããã 100mlã®ããã©ããããã©ã³äžã®1.5ïœã®æ°ŽçŽ å
ãªããŠã ã¢ã«ãããŠã ã®æžæ¿æ¶²ã«æ»Žäžã«ãã4.18
ïœã®ïŒ4aïŒ11bïŒâ4aïŒïŒïŒïŒïŒ11bâããã©ãã
ãâ2HâãïŒããã³ãºãªãã»ããâãïŒïŒïŒâïœã
âïŒïŒïŒâãªããµãžã³âïŒïŒ4HïŒãªã³ãå ããã
æ··åç©ãïŒæééæµããæ°·äžã§å·ãããéå°ã®æ°Ž
çŽ åç©ãïŒmlã®10ïŒ æ°Žé žåãããªãŠã 溶液添å ã«
ãã€ãŠå解ãããçããæ··åç©ãäžå€æ¹æããåº
äœããéããŠé€ãã溶åªãèžçºã«ããé€ããæ®ç
ç©ããšãŒãã«äžã«æº¶è§£ãããšãŒãã«æ§ã®å¡©åæ°ŽçŽ
ã§åŠçãããæ²æ®¿ããè¡šé¡ååç©ãã¡ã¿ããŒã«ïŒ
ã¢ã»ããããªã«æº¶æ¶²ããåçµæ¶ããŠ2.69ïœã®ç©è³ª
ãçæããã ããã¯èç¹259ã60âãæããã æ¬è³ªçã«åãæé ã«åŸããã次ã®ãã©ã³ã¹âïŒ
âã¢ããâïŒïŒïŒïŒïŒïŒïŒâããã©ãããâïŒâ
ãã³ãºãªãã»ãã³âïŒâãªãŒã«ããããŠã次ã®ä»¥
äžã«ç€ºãçæç©ãçæããã
ãè¡šã
å®æœäŸ ïŒ
ãã©ã³ã¹âïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ
11bâãããµãããâïŒâã¡ãã«â2HâãïŒã
ãã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãª
ããµãžã³ãã¬ãšãŒã åã®å®æœäŸã§è£œé ããïŒ4aïŒ11bïŒâïŒïŒïŒïŒ
4aïŒïŒïŒïŒïŒ11bâãããµãããâ2HâãïŒãã
ã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµ
ãžã³ã3.0mlã®ããªãšãã«ã¢ãã³åã³25mlã®å¡©å
ã¡ãã¬ã³ã®æ··åç©ãæ¹æãã25mlã®å¡©åã¡ãã¬ã³
äžã«æº¶è§£ãã1.0mlã®ãšãã«ã¯ãããã«ã¡ãŒãã®
溶液ãããã«æ»Žäžãããæ··åç©ãäžå€æ¹æããåž
å¡©é žæº¶æ¶²ã§æŽãããã®åŸé£œåå¡©åãããªãŠã ã§æŽ
ããç¡«é žãã°ãã·ãŠã äžã§ä¹Ÿç¥ããã溶åªãèžçº
ããŠãæ®çç©ã25mlã®ããã©ããããã©ã³äžã«æº¶
解ããã ãã®æº¶æ¶²ã50mlã®ããã©ããããã©ã³äžã®1.0
ïœã®æ°ŽçŽ åãªããŠã ã¢ã«ãããŠã ã®æžæ¿æ¶²ã«æ»Žäž
ãå ãããçããæ··åç©ãïŒæééæµãã氷济äž
ã§å·åŽããéå°ã®æ°ŽçŽ åç©ãæ°Žé žåãããªãŠã ã®
10ïŒ æ°Žæº¶æ¶²4.0mlã泚ææ·±ãæ·»å ããããšã«ãã€
ãŠå解ãããæ··åç©ãäžå€æ¹æããéããã液ã
èžçºä¹Ÿåºãããæ®çç©ããšãŒãã«äžã«æº¶è§£ããã
ã¬ã€ã³é žã®ãšãŒãã«æº¶æ¶²ã§åŠçããŠãã¬ãšãŒãå¡©
ãçæããããã®å¡©ãã¡ã¿ããŒã«ïŒé ¢é žãšãã«æ··
åç©ããåçµæ¶åãããšååç©ããã©ã³ã¹â
ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµ
ãããâïŒâã¡ãã«â2HâãïŒããã³ãºãªãã»ã
ããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ãã¬ãšãŒ
ããçæããã ãã®ãã®ã¯èç¹153ãïŒâãæããã æ¬è³ªçã«åãæé ã«åŸããäžã®ãã©ã³ã¹â
ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµ
ãããâ2HâãïŒããã³ãºãªãã»ããâãïŒïŒïŒ
âïœãâïŒïŒïŒâãªããµãžã³ã®ãããã«ãã©ã³ã¹
âïŒ4aïŒ11bïŒâ10âã¯ããâïŒïŒïŒïŒ4aïŒïŒïŒ
ïŒïŒ11bâãããµãããâ2HâãïŒããã³ãºãªã
ã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ã«æ¿
ããŠããã©ã³ã¹âïŒ4aïŒ11bïŒâ10âã¯ããâïŒïŒ
ïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâïŒâã¡ã
ã«â2HâãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœã
âïŒïŒïŒâãªããµãžã³ãã¬ãšãŒããçæããã ããã¯èç¹142ãïŒâãæããã å®æœäŸ ïŒ ãã©ã³ã¹âïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ
11bâãããµãããâïŒïŒ®âãžã¡ãã«â2Hâ
ãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒ
âãªããµãžã³âïŒâãšã¿ããã³ãã¬ãšãŒã å®æœäŸïŒã®æé ã«åŸã€ãŠè£œé ãããã©ã³ã¹â
ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµ
ãããâ2HâãïŒããã³ãºãªãã»ããâãïŒïŒïŒ
âïœãâïŒïŒïŒâãªããµãžã³å¡©é žå¡©1.21ïœãšãã
ãªãšãã«ã¢ãã³1.65mlã®å¡©åã¡ãã¬ã³25mläžã®æº¶
液ã10mlã®å¡©åã¡ãã¬ã³äžã«æº¶è§£ããã0.70mlã®
ã¯ããã¢ã»ãã«ã¯ãã©ã€ãã®æº¶æ¶²ã§æ»ŽäžåŠçã
ããåå¿æ··åç©ãäžå€å®€æž©ã§æ¹æããç¶ããŠæ°ŽæŽ
ããæ°Žé žåãããªãŠã åžæº¶æ¶²ã§æŽããæåŸã«å¡©å
ãããªãŠã 飜å溶液ã§æŽããåå¿æ··åç©ãç¡æ°Žç¡«
é žãã°ãã·ãŠã äžã§ä¹Ÿç¥ããèžçºä¹ŸåºããŠ1.44ïœ
ã®ãã©ã³ã¹ââã¯ããã¢ã»ãã«âïŒ4aïŒ11bïŒâ
ïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâ2Hâ
ãïŒãâãã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒ
âãªããµãžã³ãåŸãã äžã®ïŒ®âã¯ããã¢ã»ãã«èªå°äœã1.5ïœã®ãžã¡
ãã«ã¢ãã³ãå«æãã50mlã®ãšã¿ããŒã«äžã«æº¶è§£
ãã溶液ããããïŒæééæµãããåå¿æ··åç©ã
èžçºä¹Ÿåºããæ®çç©ããšãŒãã«ã§ãšããããããš
ãŒãã«æº¶æ¶²ãæ°ŽæŽãã飜å塩氎溶液ã§æŽããç¡æ°Ž
ç¡«é žãã°ãã·ãŠã äžã§ä¹Ÿç¥ããããšãŒãã«æ§å¡©å
æ°ŽçŽ ã§ä¹Ÿç¥æº¶æ¶²ãåŠçãããšå¡©é žå¡©ãšããŠïŒ®âãž
ã¡ãã«ã¢ããã¢ã»ãã«èªå°äœãçæããã 50mlã®ããã©ããããã©ã³äžã®1.0ïœã®æ°ŽçŽ å
ãªããŠã ã¢ã«ãããŠã ã®æ¹æããæžæ¿æ¶²ã«ïŒ®âãž
ã¡ãã«ã¢ããã¢ã»ãã«èªå°äœã®äžèšå¡©é žå¡©ãå°é
ã¥ã€å ãããæ··åç©ãã¢ã«ãŽã³ã®äžæŽ»æ§é°å²æ°äž
ã§ïŒæééæµãã氷济äžã§å·åŽãã1.5mlã®æ°Žã®
æ·»å ã«ãã€ãŠæ³šææ·±ãå解ãããæ··åç©ãäžå€æ¹
æãããéããŠãã液ãèžçºä¹Ÿåºãããæ®çç©ã
ãšãŒãã«äžã«æº¶è§£ãããšãŒãã«äžã®ãã¬ã€ã³é žæº¶
液ã§åŠçããŠãã¬ãšãŒãå¡©ãçæããããã®å¡©ã
ã¡ã¿ããŒã«ïŒé ¢é žãšãã«æ··åç©ããåçµæ¶ãã
ãšãååç©ãã©ã³ã¹âïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒ
ïŒïŒïŒïŒ11bâãããµãããâïŒïŒ®âãžã¡ãã«
â2HâãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœãâ
ïŒïŒïŒâãªããµãžã³âïŒâãšã¿ããã³ããã¬ãšãŒ
ãå¡©ãšããŠçæããã ããã¯èç¹116ã121âãæããã å®æœäŸ ïŒ ãã©ã³ã¹âïŒ4aïŒ11bïŒâïŒâãšãã«âïŒïŒïŒïŒ
4aïŒïŒïŒïŒïŒ11bâãããµãããâ2HâãïŒã
ãã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãª
ããµãžã³ å®æœäŸïŒã«åŸã€ãŠè£œé ãã2.41ïœã®ãã©ã³ã¹â
ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµ
ãããâ2HâãïŒããã³ãºãªãã»ãããïŒïŒïŒâ
ïœãâïŒïŒïŒâãªããµãžã³ãš3.5mlã®ããªãšãã«ã¢
ãã³ã®50mlã®å¡©åã¡ãã¬ã³äžã«æº¶è§£ããæ¹æ溶液
ã«ã25mlã®å¡©åã¡ãã¬ã³äžã«æº¶è§£ããã0.85mlã®
å¡©åã¢ã»ãã«ã®æº¶æ¶²ãå ãããæ··åç©ãäžå€æ¹æ
ããåžå¡©é žæº¶æ¶²ã§æŽããç¡æ°Žç¡«é žãã°ãã·ãŠã äž
ã§ä¹Ÿç¥ãããæ®çºç©ãèžçºã«ããé€ããæ²¹ãæ®
ããããã¯ååç©ãã©ã³ã¹âïŒ4aïŒ11bïŒâã¢ã»ã
ã«âïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâ
2HâãïŒãâãã³ãºãªãã»ãããïŒïŒïŒâïœãâ
ïŒïŒïŒâãªããµãžã³ãçæããã ããã¯èç¹97ãïŒâãæããã 15mlã®ããã©ããããã©ã³äžã«æº¶è§£ãã1.38ïœ
ã®ãã®ïŒâã¢ã»ãã«èªå°äœã«æ»Žäžã«ãã25mlã®ã
ãã©ããããã©ã³äžã®0.44ïœã®æ°ŽçŽ åãªããŠã ã¢
ã«ãããŠã ã®æžæ¿æ¶²ãå ãããåå¿æ··åç©ãçŽïŒ
æééæµããæ°·äžã§å·åŽãã1.2mlã®10ïŒ æ°Žé žå
ãããªãŠã 氎溶液ã䜿ã€ãŠæ³šææ·±ãå解ããäžå€
æ¹æãããåå¿æ··åç©ããéãã溶åªãç空äžã§
èžçºããŠæ²¹ãšãããããç空èžçãããš1.13ïœã®
ãã©ã³ã¹âïŒ4aïŒ11bïŒâïŒâãšãã«âïŒïŒïŒïŒ
4aïŒïŒïŒïŒïŒ11bâãããµãããâ2HâãïŒãã
ã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµ
ãžã³ãæ²¹ãšããŠçæããã ããã¯æ²žç¹110ã15âïŒ0.1mmHgãæããã æ¬è³ªçã«åãæé ã«åŸãããäžã®å¡©åã¢ã»ãã«
ã®ãããã«æ¬¡ã®å¡©åã¢ã·ã«ã䜿ã€ãŠæ¬¡ã®çæç©å
ã³ïŒåã¯ãã®å¡©ã瀺ãããŠããããã«çããã
11bâãããµãããâïŒâã¡ãã«â2HâãïŒã
ãã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãª
ããµãžã³ãã¬ãšãŒã åã®å®æœäŸã§è£œé ããïŒ4aïŒ11bïŒâïŒïŒïŒïŒ
4aïŒïŒïŒïŒïŒ11bâãããµãããâ2HâãïŒãã
ã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµ
ãžã³ã3.0mlã®ããªãšãã«ã¢ãã³åã³25mlã®å¡©å
ã¡ãã¬ã³ã®æ··åç©ãæ¹æãã25mlã®å¡©åã¡ãã¬ã³
äžã«æº¶è§£ãã1.0mlã®ãšãã«ã¯ãããã«ã¡ãŒãã®
溶液ãããã«æ»Žäžãããæ··åç©ãäžå€æ¹æããåž
å¡©é žæº¶æ¶²ã§æŽãããã®åŸé£œåå¡©åãããªãŠã ã§æŽ
ããç¡«é žãã°ãã·ãŠã äžã§ä¹Ÿç¥ããã溶åªãèžçº
ããŠãæ®çç©ã25mlã®ããã©ããããã©ã³äžã«æº¶
解ããã ãã®æº¶æ¶²ã50mlã®ããã©ããããã©ã³äžã®1.0
ïœã®æ°ŽçŽ åãªããŠã ã¢ã«ãããŠã ã®æžæ¿æ¶²ã«æ»Žäž
ãå ãããçããæ··åç©ãïŒæééæµãã氷济äž
ã§å·åŽããéå°ã®æ°ŽçŽ åç©ãæ°Žé žåãããªãŠã ã®
10ïŒ æ°Žæº¶æ¶²4.0mlã泚ææ·±ãæ·»å ããããšã«ãã€
ãŠå解ãããæ··åç©ãäžå€æ¹æããéããã液ã
èžçºä¹Ÿåºãããæ®çç©ããšãŒãã«äžã«æº¶è§£ããã
ã¬ã€ã³é žã®ãšãŒãã«æº¶æ¶²ã§åŠçããŠãã¬ãšãŒãå¡©
ãçæããããã®å¡©ãã¡ã¿ããŒã«ïŒé ¢é žãšãã«æ··
åç©ããåçµæ¶åãããšååç©ããã©ã³ã¹â
ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµ
ãããâïŒâã¡ãã«â2HâãïŒããã³ãºãªãã»ã
ããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ãã¬ãšãŒ
ããçæããã ãã®ãã®ã¯èç¹153ãïŒâãæããã æ¬è³ªçã«åãæé ã«åŸããäžã®ãã©ã³ã¹â
ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµ
ãããâ2HâãïŒããã³ãºãªãã»ããâãïŒïŒïŒ
âïœãâïŒïŒïŒâãªããµãžã³ã®ãããã«ãã©ã³ã¹
âïŒ4aïŒ11bïŒâ10âã¯ããâïŒïŒïŒïŒ4aïŒïŒïŒ
ïŒïŒ11bâãããµãããâ2HâãïŒããã³ãºãªã
ã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ã«æ¿
ããŠããã©ã³ã¹âïŒ4aïŒ11bïŒâ10âã¯ããâïŒïŒ
ïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâïŒâã¡ã
ã«â2HâãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœã
âïŒïŒïŒâãªããµãžã³ãã¬ãšãŒããçæããã ããã¯èç¹142ãïŒâãæããã å®æœäŸ ïŒ ãã©ã³ã¹âïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ
11bâãããµãããâïŒïŒ®âãžã¡ãã«â2Hâ
ãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒ
âãªããµãžã³âïŒâãšã¿ããã³ãã¬ãšãŒã å®æœäŸïŒã®æé ã«åŸã€ãŠè£œé ãããã©ã³ã¹â
ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµ
ãããâ2HâãïŒããã³ãºãªãã»ããâãïŒïŒïŒ
âïœãâïŒïŒïŒâãªããµãžã³å¡©é žå¡©1.21ïœãšãã
ãªãšãã«ã¢ãã³1.65mlã®å¡©åã¡ãã¬ã³25mläžã®æº¶
液ã10mlã®å¡©åã¡ãã¬ã³äžã«æº¶è§£ããã0.70mlã®
ã¯ããã¢ã»ãã«ã¯ãã©ã€ãã®æº¶æ¶²ã§æ»ŽäžåŠçã
ããåå¿æ··åç©ãäžå€å®€æž©ã§æ¹æããç¶ããŠæ°ŽæŽ
ããæ°Žé žåãããªãŠã åžæº¶æ¶²ã§æŽããæåŸã«å¡©å
ãããªãŠã 飜å溶液ã§æŽããåå¿æ··åç©ãç¡æ°Žç¡«
é žãã°ãã·ãŠã äžã§ä¹Ÿç¥ããèžçºä¹ŸåºããŠ1.44ïœ
ã®ãã©ã³ã¹ââã¯ããã¢ã»ãã«âïŒ4aïŒ11bïŒâ
ïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâ2Hâ
ãïŒãâãã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒ
âãªããµãžã³ãåŸãã äžã®ïŒ®âã¯ããã¢ã»ãã«èªå°äœã1.5ïœã®ãžã¡
ãã«ã¢ãã³ãå«æãã50mlã®ãšã¿ããŒã«äžã«æº¶è§£
ãã溶液ããããïŒæééæµãããåå¿æ··åç©ã
èžçºä¹Ÿåºããæ®çç©ããšãŒãã«ã§ãšããããããš
ãŒãã«æº¶æ¶²ãæ°ŽæŽãã飜å塩氎溶液ã§æŽããç¡æ°Ž
ç¡«é žãã°ãã·ãŠã äžã§ä¹Ÿç¥ããããšãŒãã«æ§å¡©å
æ°ŽçŽ ã§ä¹Ÿç¥æº¶æ¶²ãåŠçãããšå¡©é žå¡©ãšããŠïŒ®âãž
ã¡ãã«ã¢ããã¢ã»ãã«èªå°äœãçæããã 50mlã®ããã©ããããã©ã³äžã®1.0ïœã®æ°ŽçŽ å
ãªããŠã ã¢ã«ãããŠã ã®æ¹æããæžæ¿æ¶²ã«ïŒ®âãž
ã¡ãã«ã¢ããã¢ã»ãã«èªå°äœã®äžèšå¡©é žå¡©ãå°é
ã¥ã€å ãããæ··åç©ãã¢ã«ãŽã³ã®äžæŽ»æ§é°å²æ°äž
ã§ïŒæééæµãã氷济äžã§å·åŽãã1.5mlã®æ°Žã®
æ·»å ã«ãã€ãŠæ³šææ·±ãå解ãããæ··åç©ãäžå€æ¹
æãããéããŠãã液ãèžçºä¹Ÿåºãããæ®çç©ã
ãšãŒãã«äžã«æº¶è§£ãããšãŒãã«äžã®ãã¬ã€ã³é žæº¶
液ã§åŠçããŠãã¬ãšãŒãå¡©ãçæããããã®å¡©ã
ã¡ã¿ããŒã«ïŒé ¢é žãšãã«æ··åç©ããåçµæ¶ãã
ãšãååç©ãã©ã³ã¹âïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒ
ïŒïŒïŒïŒ11bâãããµãããâïŒïŒ®âãžã¡ãã«
â2HâãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœãâ
ïŒïŒïŒâãªããµãžã³âïŒâãšã¿ããã³ããã¬ãšãŒ
ãå¡©ãšããŠçæããã ããã¯èç¹116ã121âãæããã å®æœäŸ ïŒ ãã©ã³ã¹âïŒ4aïŒ11bïŒâïŒâãšãã«âïŒïŒïŒïŒ
4aïŒïŒïŒïŒïŒ11bâãããµãããâ2HâãïŒã
ãã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãª
ããµãžã³ å®æœäŸïŒã«åŸã€ãŠè£œé ãã2.41ïœã®ãã©ã³ã¹â
ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµ
ãããâ2HâãïŒããã³ãºãªãã»ãããïŒïŒïŒâ
ïœãâïŒïŒïŒâãªããµãžã³ãš3.5mlã®ããªãšãã«ã¢
ãã³ã®50mlã®å¡©åã¡ãã¬ã³äžã«æº¶è§£ããæ¹æ溶液
ã«ã25mlã®å¡©åã¡ãã¬ã³äžã«æº¶è§£ããã0.85mlã®
å¡©åã¢ã»ãã«ã®æº¶æ¶²ãå ãããæ··åç©ãäžå€æ¹æ
ããåžå¡©é žæº¶æ¶²ã§æŽããç¡æ°Žç¡«é žãã°ãã·ãŠã äž
ã§ä¹Ÿç¥ãããæ®çºç©ãèžçºã«ããé€ããæ²¹ãæ®
ããããã¯ååç©ãã©ã³ã¹âïŒ4aïŒ11bïŒâã¢ã»ã
ã«âïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâ
2HâãïŒãâãã³ãºãªãã»ãããïŒïŒïŒâïœãâ
ïŒïŒïŒâãªããµãžã³ãçæããã ããã¯èç¹97ãïŒâãæããã 15mlã®ããã©ããããã©ã³äžã«æº¶è§£ãã1.38ïœ
ã®ãã®ïŒâã¢ã»ãã«èªå°äœã«æ»Žäžã«ãã25mlã®ã
ãã©ããããã©ã³äžã®0.44ïœã®æ°ŽçŽ åãªããŠã ã¢
ã«ãããŠã ã®æžæ¿æ¶²ãå ãããåå¿æ··åç©ãçŽïŒ
æééæµããæ°·äžã§å·åŽãã1.2mlã®10ïŒ æ°Žé žå
ãããªãŠã 氎溶液ã䜿ã€ãŠæ³šææ·±ãå解ããäžå€
æ¹æãããåå¿æ··åç©ããéãã溶åªãç空äžã§
èžçºããŠæ²¹ãšãããããç空èžçãããš1.13ïœã®
ãã©ã³ã¹âïŒ4aïŒ11bïŒâïŒâãšãã«âïŒïŒïŒïŒ
4aïŒïŒïŒïŒïŒ11bâãããµãããâ2HâãïŒãã
ã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµ
ãžã³ãæ²¹ãšããŠçæããã ããã¯æ²žç¹110ã15âïŒ0.1mmHgãæããã æ¬è³ªçã«åãæé ã«åŸãããäžã®å¡©åã¢ã»ãã«
ã®ãããã«æ¬¡ã®å¡©åã¢ã·ã«ã䜿ã€ãŠæ¬¡ã®çæç©å
ã³ïŒåã¯ãã®å¡©ã瀺ãããŠããããã«çããã
ãè¡šã
å®æœäŸ ïŒ
ã·ã¹åã³ãã©ã³ã¹âïŒâã¢ããâïŒïŒïŒïŒïŒïŒ
ïŒâããã©ããããã³ãºãªãã»ãã³âïŒâãªãŒ
ã« 60mlã®ãšã¿ããŒã«äžã®43.84ïœïŒ0.2MïŒã®ïŒâ
ã¢ã»ãã¢ããâïŒïŒïŒâãžããããã³ãºãªãã»ã
ã³âïŒïŒ4HïŒãªã³ã®æ¹æãããæžæ¿æ¶²ãæ°·äžã§å·
åŽãã10ïœã®æ°ŽçŽ åããŠçŽ ãããªãŠã ã滎äžã
ããïŒæéåŸæº¶åªãé€ããæ®æž£ã800mlã®æ°Žäžã«
溶解ãããCHCl3ã§æœåºãããšæ²¹ãšããŠã·ã¹åã³
ãã©ã³ã¹âïŒâã¢ã»ãã¢ããâïŒïŒïŒïŒïŒïŒïŒâ
ããã©ããããã³ãºãªãã»ãã³âïŒâãªãŒã«ãäž
ããã äžã®æ²¹ïŒ10.76ïœïŒã25ïœã®50ïŒ æ°Žé žåãããªãŠ
ã ãåã³50mlã®ãšã¿ããŒã«ã®æ··åç©ãïŒæééæµ
ããå·åŽããŠæ°Žã§400mlã«åžéãããäžå€æŸçœ®ã
ããšãã©ã³ã¹âïŒâã¢ããâïŒïŒïŒïŒïŒïŒïŒâã
ãã©ããããã³ãºãªãã»ãã³âïŒâãªãŒã«ãæ²æ®¿
ããã èç¹ã¯144ã146âã§ããã åæè©Šæããã«ãšã³ããåçµæ¶ãããèç¹146
ã148â ã液ãæ¿çž®ãããšç²è£œã®ã·ã¹âïŒâã¢ããâ
ïŒïŒïŒïŒïŒïŒïŒâããã©ããããã³ãºãªãã»ãã³
âïŒâãªãŒã«ãäžãããé ¢é žãšãã«ããæ°ååçµ
æ¶ãããšçŽç²ãªã·ã¹ã¢ããã¢ã«ã³ãŒã«ãäžããã
ãã®èç¹ã¯136ã138âã§ããã å®æœäŸ ïŒ 4aïŒïŒïŒïŒïŒ11bâããããããâïŒ4aïŒ11bïŒ
â2HãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœãâ
ïŒïŒïŒâãªããµãžã³âïŒïŒ4HïŒãªã³ 200mlã®å¡©åã¡ãã¬ã³äžã®0.1Mã®ã·ã¹âïŒâã¢
ããâïŒïŒïŒïŒïŒïŒïŒâããã©ããããã³ãºãªã
ã»ãã³âïŒâãªãŒã«åã³0.11Mã®ããªãšãã«ã¢ã
ã³ã®æº¶æ¶²ãæ°·äžã§å·åŽãã50mlã®å¡©åã¡ãã¬ã³äž
ã®0.1Mã®ã¯ããã¢ã»ãã«ã¯ãã©ã€ãã滎äžããŠ
å ããã宀枩ã§äžå€æ¹æåŸã溶液ãåžå¡©é žã§æœåº
ããŠæº¶åªãèžçºãããæ®çç©ã250mlã®ã€ãœãã
ãããŒã«ãšå ±ã«æ¹æããæ°Žé žåãããªãŠã ïŒ50ïŒ
氎溶液ãšããŠïŒåœéïŒãå ãããæ··åç©ãäžå€æ¹
æããæ¿çž®ããŠæ°Žåžéãè¡šé¡ååç©ãäžãããé ¢
é žãšãã«ããåçµæ¶ããåæè©Šæã¯èç¹156â
164ããæããã å®æœäŸ ïŒ ïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµããã
ïŒ4aïŒ11bïŒ2HãïŒããã³ãºãªãã»ãããïŒïŒ
4bãâïŒïŒïŒâãªããµãžã³ãã¬ãšãŒã 4aïŒïŒïŒïŒïŒ11bâããã©ãããïŒ4aïŒ11bïŒâ
2HãïŒããã³ãºãªãã»ãããïŒïŒ4bãâïŒïŒïŒâ
ãªããµãžã³âïŒïŒ4HïŒãªã³ïŒ0.01ã¢ã«ïŒã溶液ã
ããšãã100mlã®ä¹Ÿç¥ããã©ããããã©ã³äžã®
0.005Mã®æ°ŽçŽ åãªããŠã ã¢ã«ãããŠã ã®æžæ¿æ¶²
ã«å ãããæ··åç©ãïŒæééæµããæ°·äžã§å·åŽ
ãã15ïŒ NaOHã§å解ãããäžå€æ¹æåŸãæ··å
ç©ããéããŠæº¶æ¶²ãã液ããé€ããæ®çç©ããšãŒ
ãã«äžã«æº¶è§£ãããšãŒãã«äžã®ãã¬ã€ã³é žã®æº¶æ¶²
ã§åŠçããŠè¡šé¡ååç©ãäžãããåæè©Šæãé ¢é ž
ãšãã«ããåçµæ¶ããããã®èç¹ã¯197ã198ãïŒå
解ïŒã§ããã å®æœäŸ ïŒ ïŒâãšãã«âïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãã
ãµãããïŒ4aïŒ11bïŒ2HãïŒããã³ãºãªãã»ã
ãâãïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ 25mlã®å¡©åã¡ãã¬ã³äžã®0.01Mã®ïŒïŒïŒïŒ4aïŒ
ïŒïŒïŒïŒ11bâãããµãããâïŒ4aïŒ11bïŒ2H
ãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâ
ãªããµãžã³åã³0.11Mã®ããªãšãã«ã¢ãã³ã®æº¶æ¶²
ãæ°·äžã§å·ããã10mlã®å¡©åã¡ãã¬ã³äžã®0.01M
ã®å¡©åã¢ã»ãã«ã§æ»ŽäžåŠçããã宀枩ã§äžå€æ¹æ
åŸã溶液ãåžå¡©é žã§æœåºããç¡«é žãã°ãã·ãŠã äž
ã§ä¹Ÿç¥ããã溶åªãèžçºãããšæ²¹ãæ®ããããã
10mlã®ä¹Ÿç¥ããã©ããããã©ã³äžã«æº¶è§£ãããã®
溶液ã25mlã®ããã©ããããã©ã³äžã®0.01Mã®æ°Ž
çŽ åãªããŠã ã¢ã«ãããŠã ã®æžæ¿æ¶²ã«æ»Žåããã
ïŒæééæµåŸãæ··åç©ãæ°·äžã§å·åŽãã15ïŒ æ°Žé ž
åãããªãŠã ã§å解ãããäžå€æ¹æåŸãåºäœãã
éãã溶åªãã液ããé€ããæ®çç©ã110ã
116ãïŒ0.2mmã§ã¯ãŒã²ã«ãã¢èžçãããšæ²¹ãšããŠ
è¡šé¡ååç©ãäžããã åæ§ã«åã®æè¡ã䜿çšããŠåèšã®ç¹å®ããŠè¿°ã¹
ãååç©åã¯åŒã«ãã€ãŠå å«ããä»»æã®ååç©
ã«å¯ŸããŠæ··åç©ã®ã·ã¹åã¯ã·ã¹âãã©ã³ã¹ãåŸã
ããã å®æœäŸ ïŒ é å€åŠæ¹ã®èª¿æŽ çµå£äœ¿çšã®ããã®åã 125mgã®ïŒ4aïŒ11bïŒâ
ïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâ2Hâ
ãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâ
ãªããµãžã³å¡©é žå¡©ãå«æãã1000é ã¯æ¬¡ã®åŠæ¹ã«
åŸã€ãŠè£œé ãããã æ å Gm (a) ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâã
ããµãããâ2HâãïŒãâãã³ãºãªãã»ãã
ãïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³å¡©é žå¡© 125 (b) ãžã«ã«ã·ãŠã ãã¹ããšãŒã 150 (c) ã¡ãã«ã»ã«ããŒã¹ãU.S.P.ïŒ15cpsïŒ 6.5 (d) æ»ç³ 20 (e) ã¹ãã¢ãªã³é žã«ã«ã·ãŠã 2.5 ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãã
ãµãããâ2HâãïŒããã³ãºãªãã»ãããïŒïŒïŒ
âïœãâïŒïŒïŒâãªããµãžã³å¡©é žå¡©åã³ãžã«ã«ã·
ãŠã ãã¹ããšãŒããååã«æ··åããã¡ãã«ã»ã«ã
ãŒã¹ã®7.5ïŒ æ°Žæº¶æ¶²ã§é¡ç²åããïŒçªç¯©ã«éããŠ
泚ææ·±ã也ç¥ããã也ç¥ããé¡ç²ã12çªç¯©ã«é
ããæ»ç³åã³ã¹ãã¢ãªã³é žã«ã«ã·ãŠã ãšæ··åãã
é å€ã«å§çž®ããã å®æœäŸ 10 ã«ãã»ã«åŠæ¹ã®èª¿è£œ åã ã200mgã®ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒ
ïŒïŒ11bâãããµãããâïŒâã¡ãã«â2HâãïŒã
ãã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªã
ãµãžã³ãã¬ãšãŒããå«æããçµå£äœ¿çšã®ããã®
1000åã®ïŒç硬質ãŒã©ãã³ã«ãã»ã«ã次ã®æåã
ã調補ããã æ å Gm (a) ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâã
ããµãããâïŒâã¡ãã«â2HâãïŒãâãã³ãº
ãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãž
ã³ãã¬ãšãŒã 200 (b) ä¹³ç³U.S.P. 100 (c) 殿ç²U.S.P. 10 (d) æ»ç³U.S.P. ïŒ (e) ã¹ãã¢ãªã³é žã«ã«ã·ãŠã ïŒ åŸ®ç²æ«åããææãåäžã«åæ£ãããŸã§æ··åç©
ãé©åœå¯žæ³ã®ç¡¬è³ªæ®»ã®ãŒã©ãã³ã«ãã»ã«äžã«å ã
ãã äžã®åŠæ¹ãé¡ç²åãã¹ã©ã°åãåã¯ã«ãã»ã«ã
圢æãããå転ãã€åã¯ãã¬ãŒãåäžã«çŽæ¥å§çž®
ãããåããããªããæ¹ã§äžçã®è»è³ªãŒã©ãã³ã«
ãã»ã«ã補é åºæ¥ããå¥ã®æ¹æ³ãšããŠã¯ãäžã®è³Š
圢è¬ãçç¥ãã掻æ§æåãã«ãã»ã«äžã«çŽæ¥ç²æ«
ãšããŠåæ£åºæ¥ãã å®æœäŸ 11 次ã®å®æœäŸã¯æ¬çºæã®ååç©ã§åŸãããçèåŒ
緩掻æ§ã説æããã ã¢ã«ãã€ã³èªå°ã¹ãã©ãŠãå°Ÿã®æ®æ ã¢ã«ãã€ã³æäžã«ç¶ãããŠã¹ã®å°ŸïŒã¹ãã©ãŠã
å°ŸïŒã®ç¹åŸŽã¯ä»å°Ÿéªšçã®èã®çèã®æç¶çäžæ¢åª
ä»ãªãã©ãã¯ã¹åçž®ã«ãããã®ã§ãããåè©Šéšã«
ïŒã10å¹ã®ããŠã¹ã䜿ãèšéïŒ18ã30ã°ã©ã ïŒã
ãŠæ³šå°ïŒãïŒååã«ãã€ã¬ãã¯ã¹ã¬ã©ã¹èŠ³å¯å®€ã«
å ¥ãããåç©ãè©Šéšååç©ã§ãããããã
ïŒRotorodïŒè©ŠéšïŒèŽæ»èœåã®æžå°ïŒããåŸã
ED50ã«åºã¥ããŠçŽ10mlïŒKgã®å¯Ÿæ°æäžçã§åŠç
ããã15ååŸç¡«é žã¢ã«ãã€ã³ã®æãŸããæäžéçŽ
10mlïŒKgãç®äžæ³šå°ããããŠã¹ã¯ã¹ãã©ãŠãå°Ÿã®
ååŠïŒ90ãåã¯ãã以äžã®å°Ÿã®ãã¡äžããšããŠå®
矩ïŒã«ã€ãã¢ã«ãã€ã³æäžã«ç¶ã30åã®æé芳å¯
ããã èŽæ»èœåã®æžå° ãããŒãåã³ã«ãŒã«J.Pharmacol.Exp.
Therap.121ã354ïŒ1957ïŒã®æ¹æ³ã«åŸã€ãŠã10å¹
ã®ããŠã¹çŸ€ã120ç§æ°Žå¹³å転æ£ïŒ15å転ïŒåã®ã
ããããïŒäžã«å±ãŸãèœåã«ã€ãäºåéžæããã
ããŠã¹ãè©Šéšååç©æäžããçš®ã ã®æéè©Šéšã
ãã120ç§ã®è¬ç©æå¶åæéããã®ãããããäž
ã®å¹³åæéã®å€åããŒã»ã³ããå矀ã«ã€ããŠèšç®
ããããããã®ããŒã¿ãŒã95ïŒ ã®ä¿¡é Œéçåã³åŸ
æããã€ãŠED50ã®è©äŸ¡ãããããã«ç·åœ¢ã®ååž°
ããã°ã©ã ã䜿çšããŠã³ã³ããŠãŒã¿ãŒã§åæã
ããED50ã¯ãããããäžã§ã®å¹³åæé50ïŒ æžå°
ãçããååç©æäžéãšããŠå®çŸ©ãããã çµ æ
ïŒâããã©ããããã³ãºãªãã»ãã³âïŒâãªãŒ
ã« 60mlã®ãšã¿ããŒã«äžã®43.84ïœïŒ0.2MïŒã®ïŒâ
ã¢ã»ãã¢ããâïŒïŒïŒâãžããããã³ãºãªãã»ã
ã³âïŒïŒ4HïŒãªã³ã®æ¹æãããæžæ¿æ¶²ãæ°·äžã§å·
åŽãã10ïœã®æ°ŽçŽ åããŠçŽ ãããªãŠã ã滎äžã
ããïŒæéåŸæº¶åªãé€ããæ®æž£ã800mlã®æ°Žäžã«
溶解ãããCHCl3ã§æœåºãããšæ²¹ãšããŠã·ã¹åã³
ãã©ã³ã¹âïŒâã¢ã»ãã¢ããâïŒïŒïŒïŒïŒïŒïŒâ
ããã©ããããã³ãºãªãã»ãã³âïŒâãªãŒã«ãäž
ããã äžã®æ²¹ïŒ10.76ïœïŒã25ïœã®50ïŒ æ°Žé žåãããªãŠ
ã ãåã³50mlã®ãšã¿ããŒã«ã®æ··åç©ãïŒæééæµ
ããå·åŽããŠæ°Žã§400mlã«åžéãããäžå€æŸçœ®ã
ããšãã©ã³ã¹âïŒâã¢ããâïŒïŒïŒïŒïŒïŒïŒâã
ãã©ããããã³ãºãªãã»ãã³âïŒâãªãŒã«ãæ²æ®¿
ããã èç¹ã¯144ã146âã§ããã åæè©Šæããã«ãšã³ããåçµæ¶ãããèç¹146
ã148â ã液ãæ¿çž®ãããšç²è£œã®ã·ã¹âïŒâã¢ããâ
ïŒïŒïŒïŒïŒïŒïŒâããã©ããããã³ãºãªãã»ãã³
âïŒâãªãŒã«ãäžãããé ¢é žãšãã«ããæ°ååçµ
æ¶ãããšçŽç²ãªã·ã¹ã¢ããã¢ã«ã³ãŒã«ãäžããã
ãã®èç¹ã¯136ã138âã§ããã å®æœäŸ ïŒ 4aïŒïŒïŒïŒïŒ11bâããããããâïŒ4aïŒ11bïŒ
â2HãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœãâ
ïŒïŒïŒâãªããµãžã³âïŒïŒ4HïŒãªã³ 200mlã®å¡©åã¡ãã¬ã³äžã®0.1Mã®ã·ã¹âïŒâã¢
ããâïŒïŒïŒïŒïŒïŒïŒâããã©ããããã³ãºãªã
ã»ãã³âïŒâãªãŒã«åã³0.11Mã®ããªãšãã«ã¢ã
ã³ã®æº¶æ¶²ãæ°·äžã§å·åŽãã50mlã®å¡©åã¡ãã¬ã³äž
ã®0.1Mã®ã¯ããã¢ã»ãã«ã¯ãã©ã€ãã滎äžããŠ
å ããã宀枩ã§äžå€æ¹æåŸã溶液ãåžå¡©é žã§æœåº
ããŠæº¶åªãèžçºãããæ®çç©ã250mlã®ã€ãœãã
ãããŒã«ãšå ±ã«æ¹æããæ°Žé žåãããªãŠã ïŒ50ïŒ
氎溶液ãšããŠïŒåœéïŒãå ãããæ··åç©ãäžå€æ¹
æããæ¿çž®ããŠæ°Žåžéãè¡šé¡ååç©ãäžãããé ¢
é žãšãã«ããåçµæ¶ããåæè©Šæã¯èç¹156â
164ããæããã å®æœäŸ ïŒ ïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµããã
ïŒ4aïŒ11bïŒ2HãïŒããã³ãºãªãã»ãããïŒïŒ
4bãâïŒïŒïŒâãªããµãžã³ãã¬ãšãŒã 4aïŒïŒïŒïŒïŒ11bâããã©ãããïŒ4aïŒ11bïŒâ
2HãïŒããã³ãºãªãã»ãããïŒïŒ4bãâïŒïŒïŒâ
ãªããµãžã³âïŒïŒ4HïŒãªã³ïŒ0.01ã¢ã«ïŒã溶液ã
ããšãã100mlã®ä¹Ÿç¥ããã©ããããã©ã³äžã®
0.005Mã®æ°ŽçŽ åãªããŠã ã¢ã«ãããŠã ã®æžæ¿æ¶²
ã«å ãããæ··åç©ãïŒæééæµããæ°·äžã§å·åŽ
ãã15ïŒ NaOHã§å解ãããäžå€æ¹æåŸãæ··å
ç©ããéããŠæº¶æ¶²ãã液ããé€ããæ®çç©ããšãŒ
ãã«äžã«æº¶è§£ãããšãŒãã«äžã®ãã¬ã€ã³é žã®æº¶æ¶²
ã§åŠçããŠè¡šé¡ååç©ãäžãããåæè©Šæãé ¢é ž
ãšãã«ããåçµæ¶ããããã®èç¹ã¯197ã198ãïŒå
解ïŒã§ããã å®æœäŸ ïŒ ïŒâãšãã«âïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãã
ãµãããïŒ4aïŒ11bïŒ2HãïŒããã³ãºãªãã»ã
ãâãïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ 25mlã®å¡©åã¡ãã¬ã³äžã®0.01Mã®ïŒïŒïŒïŒ4aïŒ
ïŒïŒïŒïŒ11bâãããµãããâïŒ4aïŒ11bïŒ2H
ãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâ
ãªããµãžã³åã³0.11Mã®ããªãšãã«ã¢ãã³ã®æº¶æ¶²
ãæ°·äžã§å·ããã10mlã®å¡©åã¡ãã¬ã³äžã®0.01M
ã®å¡©åã¢ã»ãã«ã§æ»ŽäžåŠçããã宀枩ã§äžå€æ¹æ
åŸã溶液ãåžå¡©é žã§æœåºããç¡«é žãã°ãã·ãŠã äž
ã§ä¹Ÿç¥ããã溶åªãèžçºãããšæ²¹ãæ®ããããã
10mlã®ä¹Ÿç¥ããã©ããããã©ã³äžã«æº¶è§£ãããã®
溶液ã25mlã®ããã©ããããã©ã³äžã®0.01Mã®æ°Ž
çŽ åãªããŠã ã¢ã«ãããŠã ã®æžæ¿æ¶²ã«æ»Žåããã
ïŒæééæµåŸãæ··åç©ãæ°·äžã§å·åŽãã15ïŒ æ°Žé ž
åãããªãŠã ã§å解ãããäžå€æ¹æåŸãåºäœãã
éãã溶åªãã液ããé€ããæ®çç©ã110ã
116ãïŒ0.2mmã§ã¯ãŒã²ã«ãã¢èžçãããšæ²¹ãšããŠ
è¡šé¡ååç©ãäžããã åæ§ã«åã®æè¡ã䜿çšããŠåèšã®ç¹å®ããŠè¿°ã¹
ãååç©åã¯åŒã«ãã€ãŠå å«ããä»»æã®ååç©
ã«å¯ŸããŠæ··åç©ã®ã·ã¹åã¯ã·ã¹âãã©ã³ã¹ãåŸã
ããã å®æœäŸ ïŒ é å€åŠæ¹ã®èª¿æŽ çµå£äœ¿çšã®ããã®åã 125mgã®ïŒ4aïŒ11bïŒâ
ïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãããµãããâ2Hâ
ãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâ
ãªããµãžã³å¡©é žå¡©ãå«æãã1000é ã¯æ¬¡ã®åŠæ¹ã«
åŸã€ãŠè£œé ãããã æ å Gm (a) ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâã
ããµãããâ2HâãïŒãâãã³ãºãªãã»ãã
ãïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³å¡©é žå¡© 125 (b) ãžã«ã«ã·ãŠã ãã¹ããšãŒã 150 (c) ã¡ãã«ã»ã«ããŒã¹ãU.S.P.ïŒ15cpsïŒ 6.5 (d) æ»ç³ 20 (e) ã¹ãã¢ãªã³é žã«ã«ã·ãŠã 2.5 ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãã
ãµãããâ2HâãïŒããã³ãºãªãã»ãããïŒïŒïŒ
âïœãâïŒïŒïŒâãªããµãžã³å¡©é žå¡©åã³ãžã«ã«ã·
ãŠã ãã¹ããšãŒããååã«æ··åããã¡ãã«ã»ã«ã
ãŒã¹ã®7.5ïŒ æ°Žæº¶æ¶²ã§é¡ç²åããïŒçªç¯©ã«éããŠ
泚ææ·±ã也ç¥ããã也ç¥ããé¡ç²ã12çªç¯©ã«é
ããæ»ç³åã³ã¹ãã¢ãªã³é žã«ã«ã·ãŠã ãšæ··åãã
é å€ã«å§çž®ããã å®æœäŸ 10 ã«ãã»ã«åŠæ¹ã®èª¿è£œ åã ã200mgã®ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒ
ïŒïŒ11bâãããµãããâïŒâã¡ãã«â2HâãïŒã
ãã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªã
ãµãžã³ãã¬ãšãŒããå«æããçµå£äœ¿çšã®ããã®
1000åã®ïŒç硬質ãŒã©ãã³ã«ãã»ã«ã次ã®æåã
ã調補ããã æ å Gm (a) ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâã
ããµãããâïŒâã¡ãã«â2HâãïŒãâãã³ãº
ãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãž
ã³ãã¬ãšãŒã 200 (b) ä¹³ç³U.S.P. 100 (c) 殿ç²U.S.P. 10 (d) æ»ç³U.S.P. ïŒ (e) ã¹ãã¢ãªã³é žã«ã«ã·ãŠã ïŒ åŸ®ç²æ«åããææãåäžã«åæ£ãããŸã§æ··åç©
ãé©åœå¯žæ³ã®ç¡¬è³ªæ®»ã®ãŒã©ãã³ã«ãã»ã«äžã«å ã
ãã äžã®åŠæ¹ãé¡ç²åãã¹ã©ã°åãåã¯ã«ãã»ã«ã
圢æãããå転ãã€åã¯ãã¬ãŒãåäžã«çŽæ¥å§çž®
ãããåããããªããæ¹ã§äžçã®è»è³ªãŒã©ãã³ã«
ãã»ã«ã補é åºæ¥ããå¥ã®æ¹æ³ãšããŠã¯ãäžã®è³Š
圢è¬ãçç¥ãã掻æ§æåãã«ãã»ã«äžã«çŽæ¥ç²æ«
ãšããŠåæ£åºæ¥ãã å®æœäŸ 11 次ã®å®æœäŸã¯æ¬çºæã®ååç©ã§åŸãããçèåŒ
緩掻æ§ã説æããã ã¢ã«ãã€ã³èªå°ã¹ãã©ãŠãå°Ÿã®æ®æ ã¢ã«ãã€ã³æäžã«ç¶ãããŠã¹ã®å°ŸïŒã¹ãã©ãŠã
å°ŸïŒã®ç¹åŸŽã¯ä»å°Ÿéªšçã®èã®çèã®æç¶çäžæ¢åª
ä»ãªãã©ãã¯ã¹åçž®ã«ãããã®ã§ãããåè©Šéšã«
ïŒã10å¹ã®ããŠã¹ã䜿ãèšéïŒ18ã30ã°ã©ã ïŒã
ãŠæ³šå°ïŒãïŒååã«ãã€ã¬ãã¯ã¹ã¬ã©ã¹èŠ³å¯å®€ã«
å ¥ãããåç©ãè©Šéšååç©ã§ãããããã
ïŒRotorodïŒè©ŠéšïŒèŽæ»èœåã®æžå°ïŒããåŸã
ED50ã«åºã¥ããŠçŽ10mlïŒKgã®å¯Ÿæ°æäžçã§åŠç
ããã15ååŸç¡«é žã¢ã«ãã€ã³ã®æãŸããæäžéçŽ
10mlïŒKgãç®äžæ³šå°ããããŠã¹ã¯ã¹ãã©ãŠãå°Ÿã®
ååŠïŒ90ãåã¯ãã以äžã®å°Ÿã®ãã¡äžããšããŠå®
矩ïŒã«ã€ãã¢ã«ãã€ã³æäžã«ç¶ã30åã®æé芳å¯
ããã èŽæ»èœåã®æžå° ãããŒãåã³ã«ãŒã«J.Pharmacol.Exp.
Therap.121ã354ïŒ1957ïŒã®æ¹æ³ã«åŸã€ãŠã10å¹
ã®ããŠã¹çŸ€ã120ç§æ°Žå¹³å転æ£ïŒ15å転ïŒåã®ã
ããããïŒäžã«å±ãŸãèœåã«ã€ãäºåéžæããã
ããŠã¹ãè©Šéšååç©æäžããçš®ã ã®æéè©Šéšã
ãã120ç§ã®è¬ç©æå¶åæéããã®ãããããäž
ã®å¹³åæéã®å€åããŒã»ã³ããå矀ã«ã€ããŠèšç®
ããããããã®ããŒã¿ãŒã95ïŒ ã®ä¿¡é Œéçåã³åŸ
æããã€ãŠED50ã®è©äŸ¡ãããããã«ç·åœ¢ã®ååž°
ããã°ã©ã ã䜿çšããŠã³ã³ããŠãŒã¿ãŒã§åæã
ããED50ã¯ãããããäžã§ã®å¹³åæé50ïŒ æžå°
ãçããååç©æäžéãšããŠå®çŸ©ãããã çµ æ
ãè¡šã
ã¬ãšãŒã
ïŒ ãã©ã³ã¹ç°æ§äœ (i.pïŒè ¹è å )
å®æœäŸ 12 次ã®å®æœäŸã¯æ¬çºæã®ååç©ã§åŸãããé®ç掻
æ§ã説æããã ïŒã10å¹ã®ããŠã¹çŸ€ã«æãŸããçµè·¯ããïŒãã
ãè ¹è å ã§ã¯ãªãïŒè©Šéšååç©ã®ïŒåã¯ãã以äž
ã®æäžããããéžã°ããæéã«ããŠã¹ã«é ¢é žã
0.4mlïŒ0.25ïŒ ïœïŒïœæº¶æ¶²ïŒè ¹è å ïŒi.p.ïŒæäžã
ããïŒååŸãããŠã¹ã15å芳å¯ããŠèº«ãã ãïŒè ¹
ã®èŠæ¶ïŒã®å€èŠ³ã枬å®ããåããŠã¹ã®èº«ãã ãæ°
ã決å®ããã 15åã®èŠ³å¯æéã«èº«ãã ããããªãããŠã¹ã§é®
çãææãšèãããED50枬å®ã«ã¯10å¹ã®ããŠã¹
矀äžã§ïŒåã¯ãã以äžã®ååç©æäžãè©Šéšããã
次ã®é®ç掻æ§ED50ã芳å¯æž¬å®ããã
ïŒ ãã©ã³ã¹ç°æ§äœ (i.pïŒè ¹è å )
å®æœäŸ 12 次ã®å®æœäŸã¯æ¬çºæã®ååç©ã§åŸãããé®ç掻
æ§ã説æããã ïŒã10å¹ã®ããŠã¹çŸ€ã«æãŸããçµè·¯ããïŒãã
ãè ¹è å ã§ã¯ãªãïŒè©Šéšååç©ã®ïŒåã¯ãã以äž
ã®æäžããããéžã°ããæéã«ããŠã¹ã«é ¢é žã
0.4mlïŒ0.25ïŒ ïœïŒïœæº¶æ¶²ïŒè ¹è å ïŒi.p.ïŒæäžã
ããïŒååŸãããŠã¹ã15å芳å¯ããŠèº«ãã ãïŒè ¹
ã®èŠæ¶ïŒã®å€èŠ³ã枬å®ããåããŠã¹ã®èº«ãã ãæ°
ã決å®ããã 15åã®èŠ³å¯æéã«èº«ãã ããããªãããŠã¹ã§é®
çãææãšèãããED50枬å®ã«ã¯10å¹ã®ããŠã¹
矀äžã§ïŒåã¯ãã以äžã®ååç©æäžãè©Šéšããã
次ã®é®ç掻æ§ED50ã芳å¯æž¬å®ããã
ãè¡šã
ïŒ ãã©ã³ã¹ç°æ§äœ
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ ã·ã¹åã³ãã©ã³ã¹ç°æ§äœããšãã³ããªããŒåœ¢
ãå«ããåŒ ãæããïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11b
âãããµãããâ2HâãïŒããã³ãºãªãã»ãã
ãïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ãåã³è£œè¬åŠ
çã«åãå ¥ãããããã®å¡©ïŒåŒäžïŒ²åã³R1ã¯
åã æ°ŽçŽ ããã«ãªããã¯ããåã³äœçŽã¢ã«ãã«ã§
ããã R2ã¯æ°ŽçŽ ãäœçŽã¢ã«ãã«ãããšãã«äœçŽã¢ã«
ãã«ãäœçŽã¢ã«ã³ãã·äœçŽã¢ã«ãã«ãã·ã¯ããã
ãã«ã¡ãã«ãïŒâãã©ãã«ã¡ãã«ãåã³R3ãšR4
ãååæ°ŽçŽ åã¯äœçŽã¢ã«ãã«ã§ããäœçŽã¢ã«ãã«
ãåŒããããªã矀ããéžã°ãããïŒã ïŒ R2ãæ°ŽçŽ ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã®å
åç©ã ïŒ R2ãäœçŽã¢ã«ãã«ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬
ïŒé ã®ååç©ã ïŒ ïŒ²ãšR1ãæ°ŽçŽ ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
ã«ããååç©ã ïŒ ãã©ã³ã¹ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ
11bâãããµãããâ2HâãïŒããã³ãºãªãã»ã
ããïŒïŒïŒâïœãâïŒïŒïŒãªããµãžã³åã³ãã®è£œ
è¬äžåãå ¥ããããå¡©ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒ
é ã®ååç©ã ïŒ ãã©ã³ã¹ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ
11bâãããµãããâïŒâã¡ãã«â2HâãïŒãã
ã³ãŸãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãž
ã³åã³ãã®è£œè¬äžåãå ¥ããããå¡©ã§ãã第ïŒé
ã®ååç©ã ïŒ ãã©ã³ã¹ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ
11bâãããµãããâïŒâïŒããšãã«ã¡ãã«ïŒâ2H
âãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒ
âãªããµãžã³åã³ãã®è£œè¬äžåãå ¥ããããå¡©ã§
ãã第ïŒé ã®ååç©ã ïŒ åŒ ã®ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãã
ãµãããâ2HâãïŒããã³ãºãªãã»ãããïŒïŒïŒ
âïœãâïŒïŒïŒâãªããµãžã³ïŒåŒäžïŒ²ãšR1ã¯åã
æ°ŽçŽ ããã«ãªããã¯ãããåã³äœçŽã¢ã«ãã«ãã
éžã°ãR2ã¯æ°ŽçŽ ãäœçŽã¢ã«ãã«ãããšãã«äœçŽ
ã¢ã«ãã«ãäœçŽã¢ã«ã³ãã·äœçŽã¢ã«ãã«ãã·ã¯ã
ãããã«ã¡ãã«ãïŒâãã©ãã«ã¡ãã«åã³R3ãš
R4ãåã æ°ŽçŽ åã¯äœçŽã¢ã«ãã«ã§ããäœçŽã¢ã«
ãã«ãåŒããããªã矀ããéžã°ããïŒã®è£œæ³ ã«æŒãŠã (1) åŒ ïŒåŒäžïŒ²åã³R1ã¯äžã«å®çŸ©ã®éãïŒãæãã
ïŒâã¢ããâïŒïŒïŒïŒïŒïŒïŒâããã©ãããâ
ïŒâãã³ãºãªãã»ãã³âïŒãªãŒã«ãã¯ããã¢ã»
ãã«ã¯ãã©ã€ããšåå¿ãããŠ2â²âã¯ããââ
ïŒïŒïŒïŒïŒïŒïŒïŒâããã©ãããâïŒâããã
ãã·âïŒâãã³ãºãªãã»ãã³âïŒâã€ã«ïŒã¢ã»
ãã¢ããã補é ã (2) äžèšã¢ã»ãã¢ããæ°Žé žåãããªãŠã ã§ç°åã
ãŠåŒ ãæããïŒ4aïŒ11bïŒâ4aïŒïŒïŒïŒïŒ11bâãã
ã©ãããâ2HâãïŒããã³ãºãªãã»ãããïŒïŒ
ïŒâïœãâïŒïŒïŒâãªããµãžã³âïŒïŒ4HïŒãªã³
ã補é ãã (3) äžèšïŒïŒïŒâãªããµãžã³âïŒïŒ4HïŒãªã³ãé
å ãåŒ ãæããïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ
11bâãããµãããâ2HâãïŒããã³ãºãªãã»
ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³ã補
é ãã (4) äžèšãã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒ
ïŒâãªããµãžã³ãé žå¡©åç©åã¯é žç¡æ°Žç©ã§ã¢ã·
ã«åããŠåŒ ãæããâã¢ã·ã«âïŒ4aïŒ11bïŒâïŒïŒïŒïŒ
4aïŒïŒïŒïŒïŒ11bâãããµãããâ2HâãïŒã
ãã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãª
ããµãžã³ã補é ãã (5) äžèšïŒ®âã¢ã·ã«âãã³ãºãªãã»ãããïŒïŒïŒ
âïœãâïŒïŒïŒâãªããµãžã³ãéå ããŠææã®
ïŒ4aïŒ11bïŒâïŒïŒïŒïŒ4aïŒïŒïŒïŒïŒ11bâãã
ãµãããâ2HâãïŒããã³ãºãªãã»ãããïŒïŒ
ïŒâïœãâïŒïŒïŒâãªããµãžã³ãããããåå
ããããšãããªãæ¹æ³ã
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46644283A | 1983-02-15 | 1983-02-15 | |
| US466442 | 1983-02-15 | ||
| US562757 | 1983-12-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59155387A JPS59155387A (ja) | 1984-09-04 |
| JPH0372229B2 true JPH0372229B2 (ja) | 1991-11-18 |
Family
ID=23851767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2530784A Granted JPS59155387A (ja) | 1983-02-15 | 1984-02-15 | ïŒïŒšâãïŒããã³ãºãªãã»ãããïŒïŒïŒâïœãâïŒïŒïŒâãªããµãžã³èªå°äœ |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS59155387A (ja) |
| ZA (1) | ZA841009B (ja) |
-
1984
- 1984-02-10 ZA ZA841009A patent/ZA841009B/xx unknown
- 1984-02-15 JP JP2530784A patent/JPS59155387A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ZA841009B (en) | 1984-09-26 |
| JPS59155387A (ja) | 1984-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS6049192B2 (ja) | æ°èŠçœ®æãã³ãºã¢ããããã®è£œé æ¹æ³åã³ãããæå¹æåãšããå粟ç¥è¬ | |
| JPH0819065B2 (ja) | ãã³ãŸèåã·ã¯ãã¢ã«ã«ã³ããã³ãªããµâããã³ãã¢âã·ã¯ãã¢ã«ã«ã³ãã©ã³ã¹âïŒïŒïŒâãžã¢ãã³èªå°äœ | |
| JPS6332072B2 (ja) | ||
| JP3130040B2 (ja) | ã¢ãªãŒã«ã¢ã«ããªã³ååç©ã補é æ¹æ³ããã³äœ¿çš | |
| US4169108A (en) | 5(OR 6)-[(Substituted-amino)alkyl]-2,3-naphthalenediols | |
| EP0179855B1 (en) | Dopamine agonists | |
| US4461895A (en) | Dibenzo(de,g)quinolines | |
| AU622911B2 (en) | Novel benzazepine derivatives | |
| CA1207774A (en) | 1-phenylindazol-3-one compounds, a method of preparing them and pharmaceutical compositions containing these compounds | |
| JPS6216947B2 (ja) | ||
| EP0116373B1 (en) | 2h-(1) benzoxepino(5,4-b)-1,4-oxazine derivatives | |
| EP0116372B1 (en) | 2h-(1) benzoxepino (5,4-b)-1,4 oxazine derivatives | |
| PL108610B1 (en) | Method of producing cis-4a-phenylo-2-substituted-2,3,4,4a,5,6,7,7a-octahydro-1h-2-pyrindines | |
| JPH0372229B2 (ja) | ||
| KR100382998B1 (ko) | 6-ë©í¡ì-1h-벀조ížëŠ¬ìì¡ž-5-칎륎복ì¬ë¯žëì ë첎,ê·žì ì¡°ë°©ë²ë°ê·žê²ìíšì íëììœì¡°ì±ë¬Œ | |
| JPS6011901B2 (ja) | æ°èŠã®èèªæ眮æãããïŒâããšãã«âãããªãžã³ | |
| US4766212A (en) | 2H-[1]benzoxepino[5,4-b]-1,4-oxazine derivatives | |
| JPH03120271A (ja) | æèè¡æŽ»æ§ãæãããã§ãã«ã¢ã«ãã«ã¢ãã³èªå°äœ | |
| US4350814A (en) | Pyrrolo [3,4-c]quinoline compounds | |
| JPS6130588A (ja) | ãã³ãŸãïœããïŒïŒïŒãããããªãžã³ããã®è£œé æ¹æ³åã³ãã®äœ¿çšã䞊ã³ã«ãããã®ååç©ãå«æããèª¿è£œå€ | |
| US4965259A (en) | Dioxazocine derivatives compositions and methods containing them having antidepressive, spasmolytic, anticonvulsive, and antiarrhythmic properties | |
| JPH0153275B2 (ja) | ||
| EP2438050B1 (en) | Novel derivatives of aryl-{4-halogeno-4-[aminomethyl]-piperidin-1-yl}-methanone, their method of preparation and their use as medicinal products | |
| CS239947B2 (en) | Processing of new benzazepin derivatives | |
| US4318909A (en) | Benzoxazocines |